STOCK TITAN

FDCTech (FDCT) posts strong Q1 2026 profit on 155% revenue surge and higher cash

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

FDCTech, Inc. reported sharply improved results for the three months ended March 31, 2026. Revenue rose to $15,214,492 from $5,976,948 a year earlier, an increase of about 154.6%, driven mainly by Brokerage (Trading) revenue of $12,009,418.

Gross profit reached $11,631,154 and operating income was $6,855,309, leading to net income of $6,869,920, or $0.016 per share, compared with nearly breakeven a year ago. Cash and cash equivalents grew to $36,891,541, and total assets were $72,195,266 versus liabilities of $38,582,773.

Working capital surplus improved to $30,169,554, and accumulated surplus rose to $9,984,473. Management concluded no conditions raise substantial doubt about continuing as a going concern. The company still carries sizable related-party receivables and remains involved in several regulatory and commercial legal proceedings.

Positive

  • Material revenue and profit inflection: Q1 2026 revenue rose to $15.2M (about 154.6% growth), with net income improving to $6.9M and EPS of $0.016. Cash of $36.9M and working capital surplus of $30.2M support management’s conclusion that no going concern uncertainty exists.

Negative

  • Exposure to related parties and regulatory/legal outcomes: Related-party receivables total $30.2M, and a $2.0M non-interest-bearing seller note depends on a future uplisting. The group is appealing a €419,997 FIAU administrative penalty and is involved in other litigation, which could impact future cash flows.

Insights

FDCT posts strong Q1 revenue and profit, but with legal and related-party complexities.

FDCTech delivered a step-change quarter: revenue of $15.2M was up about 154.6%, with Brokerage (Trading) contributing $12.0M. Operating income of $6.9M translated into net income of $6.9M and EPS of $0.016, versus near-zero earnings last year.

Cash rose to $36.9M, total assets reached $72.2M, and working capital surplus expanded to $30.2M. Management now sees no events that raise substantial doubt about going concern, a notable shift supported by positive operating cash flow of $40.7M, helped by higher customer funds on the balance sheet.

However, the balance sheet shows $30.2M of related-party receivables and restructured advances involving Alchemy DMCC and other affiliates, plus a $2.0M non-interest-bearing business acquisition loan due upon a future uplisting. Ongoing appeals of a €419,997 FIAU administrative penalty and other litigation could affect future results depending on outcomes and any associated payments.

Q1 2026 Revenue $15,214,492 Three months ended March 31, 2026; up ~154.6% YoY
Q1 2026 Net Income $6,869,920 Three months ended March 31, 2026
Q1 2026 EPS $0.016 per share Basic and diluted, 423,084,729 average shares
Brokerage (Trading) Revenue $12,009,418 Three months ended March 31, 2026
Cash and Cash Equivalents $36,891,541 Balance as of March 31, 2026
Total Assets $72,195,266 As of March 31, 2026
Total Liabilities $38,582,773 As of March 31, 2026
Working Capital Surplus $30,169,554 Current assets minus current liabilities, March 31, 2026
Related-Party Receivables $30,154,645 Balance as of March 31, 2026
FIAU Administrative Penalty €419,997 Penalty imposed on Alchemy Markets Ltd., under appeal
Series B Convertible Preferred Stock financial
"The Series B Certificate of Designation designates 3,000,000 shares of the Company’s authorized preferred stock as “Series B Convertible Preferred Stock” and establishes the rights, preferences, privileges, and restrictions of such shares"
Series B convertible preferred stock is a class of shares sold during a later-stage private financing that combines features of a loan and common stock: it usually pays priority dividends or has a priority claim if the company is sold, and it can be converted into common shares under predefined rules. Investors care because these shares affect ownership stakes and payout order—like having a reserved place in line and a ticket that can turn into regular ownership—so they influence potential returns and dilution for other shareholders.
going concern financial
"Management has evaluated the Company’s ability to continue as a going concern in accordance with Financial Accounting Standards Board Accounting Standards Codification Subtopic 205-40"
A going concern is a business that is expected to continue its operations and meet its obligations for the foreseeable future, rather than shutting down or selling off assets. This assumption matters to investors because it indicates stability and ongoing profitability, making the business a more reliable investment. Think of it as believing a restaurant will stay open and serve customers, rather than closing down suddenly.
ASC 606, Revenue from Contracts with Customers financial
"On January 1, 2019, the Company adopted ASU 2014-09 Revenue from Contracts with Customers and accounts for revenue contracts with customers by applying Accounting Standards Codification Topic 606"
Margin Brokerage financial
"The Company operates through four complementary business segments, as follows (a) Margin Brokerage"
noncontrolling interest financial
"AD Advisory Services Ltd. (ADS) is consolidated as a majority-owned subsidiary with the remaining 49.00% recognized as a noncontrolling interest in the consolidated balance sheet and statements of operations"
The portion of a business owned by investors other than the controlling owner when one company has control of another; it represents outside shareholders’ share of the subsidiary’s assets and profits. For investors, it matters because those outside claims reduce the amount of profit and net assets attributable to the parent owner — similar to saying part of a pizza belongs to someone else — and thus affects earnings, book value and valuation.
Business acquisition loan financial
"As of March 31, 2026, the Company had outstanding seller financing obligations in the aggregate amount of $2,350,000, presented as Business acquisition loan on the consolidated balance sheets"
Revenue $15,214,492 +154.6% YoY
Net income $6,869,920
EPS (basic and diluted) $0.016
false Q1 --12-31 0001722731 0001722731 2026-01-01 2026-03-31 0001722731 2026-05-15 0001722731 2026-03-31 0001722731 2025-12-31 0001722731 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001722731 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001722731 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001722731 2025-01-01 2025-03-31 0001722731 us-gaap:TechnologyServiceMember 2026-01-01 2026-03-31 0001722731 us-gaap:TechnologyServiceMember 2025-01-01 2025-03-31 0001722731 FDCT:WealthManagementMember 2026-01-01 2026-03-31 0001722731 FDCT:WealthManagementMember 2025-01-01 2025-03-31 0001722731 FDCT:InvestmentAndBrokerageMember 2026-01-01 2026-03-31 0001722731 FDCT:InvestmentAndBrokerageMember 2025-01-01 2025-03-31 0001722731 us-gaap:PreferredStockMember 2024-12-31 0001722731 us-gaap:CommonStockMember 2024-12-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001722731 FDCT:SubscriptionReceivableMember 2024-12-31 0001722731 us-gaap:RetainedEarningsMember 2024-12-31 0001722731 2024-12-31 0001722731 us-gaap:PreferredStockMember 2025-12-31 0001722731 us-gaap:CommonStockMember 2025-12-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001722731 FDCT:SubscriptionReceivableMember 2025-12-31 0001722731 us-gaap:RetainedEarningsMember 2025-12-31 0001722731 us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001722731 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001722731 FDCT:SubscriptionReceivableMember 2025-01-01 2025-03-31 0001722731 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001722731 us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001722731 FDCT:SubscriptionReceivableMember 2026-01-01 2026-03-31 0001722731 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001722731 us-gaap:PreferredStockMember 2025-03-31 0001722731 us-gaap:CommonStockMember 2025-03-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001722731 FDCT:SubscriptionReceivableMember 2025-03-31 0001722731 us-gaap:RetainedEarningsMember 2025-03-31 0001722731 2025-03-31 0001722731 us-gaap:PreferredStockMember 2026-03-31 0001722731 us-gaap:CommonStockMember 2026-03-31 0001722731 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001722731 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001722731 FDCT:SubscriptionReceivableMember 2026-03-31 0001722731 us-gaap:RetainedEarningsMember 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember 2025-03-31 0001722731 FDCT:ADAdvisoryServicesLtdMember 2026-03-31 0001722731 FDCT:ADAdvisoryServicesLtdMember 2026-01-01 2026-03-31 0001722731 FDCT:AlchemyMarketsLtdMember 2026-03-31 0001722731 FDCT:AlchemyMarketsLtdMember 2026-01-01 2026-03-31 0001722731 FDCT:AlchemyPrimeLtdMember 2026-03-31 0001722731 FDCT:AlchemyPrimeLtdMember 2026-01-01 2026-03-31 0001722731 FDCT:AlchemytechLtdMember 2026-03-31 0001722731 FDCT:AlchemytechLtdMember 2026-01-01 2026-03-31 0001722731 FDCT:AlchemyInternationalLtdMember 2026-03-31 0001722731 FDCT:AlchemyInternationalLtdMember 2026-01-01 2026-03-31 0001722731 FDCT:XoalaAsiaMember 2026-03-31 0001722731 FDCT:XoalaAsiaMember 2026-01-01 2026-03-31 0001722731 FDCT:PrimeIntermarketGroupEurasiaMember 2026-03-31 0001722731 FDCT:PrimeIntermarketGroupEurasiaMember 2026-01-01 2026-03-31 0001722731 2025-09-03 0001722731 2025-09-04 0001722731 2025-09-04 2025-09-04 0001722731 us-gaap:SeriesBPreferredStockMember 2026-03-24 0001722731 us-gaap:SeriesBPreferredStockMember 2026-03-24 2026-03-24 0001722731 2021-09-03 0001722731 us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2026-01-01 2026-03-31 0001722731 us-gaap:SalesRevenueNetMember FDCT:SalesAndMarketingOneMember FDCT:CustomerMember 2025-01-01 2025-03-31 0001722731 FDCT:ShareSaleAgreementMember 2026-01-01 2026-03-31 0001722731 2023-09-23 0001722731 2025-01-01 2025-12-31 0001722731 us-gaap:SoftwareInDevelopmentMember 2026-03-31 0001722731 srt:MinimumMember 2026-03-31 0001722731 srt:MaximumMember 2026-03-31 0001722731 FDCT:PeriodEndUSDToAUDMember 2026-03-31 0001722731 FDCT:PeriodEndUSDToAUDMember 2025-12-31 0001722731 FDCT:PeriodEndUSDToEURMember 2026-03-31 0001722731 FDCT:PeriodEndUSDToEURMember 2025-12-31 0001722731 FDCT:PeriodEndUSDToGBPMember 2026-03-31 0001722731 FDCT:PeriodEndUSDToGBPMember 2025-12-31 0001722731 FDCT:AverageEndUSDToAUDMember 2026-03-31 0001722731 FDCT:AverageEndUSDToAUDMember 2025-03-31 0001722731 FDCT:AverageEndUSDToEURMember 2026-03-31 0001722731 FDCT:AverageEndUSDToEURMember 2025-03-31 0001722731 FDCT:AverageEndUSDToGBPMember 2026-03-31 0001722731 FDCT:AverageEndUSDToGBPMember 2025-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:CommonStockMember 2026-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:SeriesAPreferredStockMember 2026-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:SeriesBPreferredStockMember 2026-03-31 0001722731 FDCT:MrGopeSKundnanaiMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 FDCT:AlchemyDMCCMember 2026-03-31 0001722731 FDCT:AlchemyInternationalLtdMember 2026-03-31 0001722731 srt:AffiliatedEntityMember 2026-03-31 0001722731 FDCT:AlchemyInternationalLtdMember 2025-12-31 0001722731 FDCT:AlchemyPrimeLimitedMember 2026-03-31 0001722731 FDCT:FDCTechIncMember 2026-03-31 0001722731 FDCT:AILToAlchemyDMCCMember 2025-12-31 0001722731 srt:AffiliatedEntityMember 2025-12-31 0001722731 FDCT:MitchellEaglsteinMember 2026-01-01 2026-03-31 0001722731 FDCT:ImranFirozMember 2026-01-01 2026-03-31 0001722731 FDCT:SyncCapitalLimitedMember 2026-03-31 0001722731 FDCT:BankOfAmericaMember 2016-06-01 0001722731 FDCT:BankOfAmericaMember srt:MinimumMember 2016-06-01 0001722731 FDCT:BankOfAmericaMember srt:MaximumMember 2016-06-01 0001722731 FDCT:BankOfAmericaMember 2016-06-01 2016-06-01 0001722731 FDCT:BankOfAmericaMember 2026-03-31 0001722731 FDCT:BankOfAmericaMember 2025-12-31 0001722731 FDCT:PaycheckProtectionProgramMember 2020-05-01 2020-05-01 0001722731 FDCT:PaycheckProtectionProgramMember 2020-05-01 0001722731 FDCT:PaycheckProtectionProgramMember 2026-03-31 0001722731 FDCT:PaycheckProtectionProgramMember 2025-12-31 0001722731 FDCT:SmallBusinessAdministrationMember 2020-05-22 2020-05-22 0001722731 FDCT:SmallBusinessAdministrationMember 2020-05-22 0001722731 FDCT:SmallBusinessAdministrationMember 2026-03-31 0001722731 FDCT:SmallBusinessAdministrationMember 2025-12-31 0001722731 FDCT:AlchemyMarketsLtdMember 2026-03-31 0001722731 FDCT:SyncCapitalLimitedMember 2026-03-31 0001722731 FDCT:IrvineMember 2026-01-01 2026-03-31 0001722731 FDCT:NYMember 2026-01-01 2026-03-31 0001722731 FDCT:ADSOfficeMember 2026-01-01 2026-03-31 0001722731 FDCT:GeneralAndAdministrativeExpensesMember 2019-02-01 2023-07-31 0001722731 FDCT:GeneralAndAdministrativeExpensesMember 2023-07-01 2026-03-31 0001722731 FDCT:GeneralAndAdministrativeExpensesMember 2026-01-01 2026-03-31 0001722731 FDCT:ATECHOfficeMember 2026-01-01 2026-03-31 0001722731 FDCT:AMLOfficeMember 2024-07-11 2024-07-11 0001722731 FDCT:AMLSalesOfficeMember 2023-07-01 2023-07-01 0001722731 FDCT:AMLSalesOfficeMember 2023-07-01 0001722731 FDCT:APLOfficeMember 2024-12-20 0001722731 FDCT:APLOfficeMember 2024-12-20 2024-12-20 0001722731 FDCT:ChiefExecutiveOfficerAndChiefFinancialOfficerMember 2026-01-01 2026-03-31 0001722731 2021-02-12 0001722731 2022-02-16 0001722731 2022-02-17 0001722731 2022-02-17 2022-02-17 0001722731 2026-03-24 2026-03-24 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesAPreferredStockMember 2023-11-30 2023-11-30 0001722731 FDCT:AlchemyPrimeHoldingsLtdMember us-gaap:SeriesAPreferredStockMember 2023-11-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:MitchellMEaglsteinMember 2024-01-30 2024-01-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:FelixRHongMember 2024-01-30 2024-01-30 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2023-11-30 2023-11-30 0001722731 FDCT:AlchemyMarketsLtdMember us-gaap:SeriesBPreferredStockMember 2023-11-30 0001722731 FDCT:AlchemyPrimeLtdMember us-gaap:SeriesBPreferredStockMember 2023-11-30 0001722731 FDCT:MitchellMEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:MitchellMEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:ImranFirozMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:ImranFirozMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:FRHGroupCorpMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:FRHGroupCorpMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:WilliamBBarnettMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:WilliamBBarnettMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:SusanEEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:SusanEEaglsteinMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-04 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-04 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 2024-01-30 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 0001722731 FDCT:NickyGKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 2024-01-30 0001722731 FDCT:NickyGKundnaniMember us-gaap:SeriesBPreferredStockMember 2024-01-30 0001722731 us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-03-31 0001722731 FDCT:MitchEaglsteinMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:MitchEaglsteinMember 2024-12-31 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:GopeSKundnaniMember 2024-12-31 0001722731 FDCT:OfficersAndDirectorsMember us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-12-31 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:OfficersAndDirectorsMember 2024-12-31 0001722731 FDCT:MitchellEaglsteinMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 FDCT:ImranFirozMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 FDCT:FelixRHongMember us-gaap:SeriesAPreferredStockMember 2016-12-12 2016-12-12 0001722731 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001722731 FDCT:MitchellEaglsteinMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-01-31 0001722731 FDCT:ImranFirozMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-01-31 0001722731 us-gaap:SeriesAPreferredStockMember 2023-09-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:MitchellEaglsteinMember 2023-09-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:GopeSKundnaniMember 2023-09-30 0001722731 us-gaap:SeriesAPreferredStockMember FDCT:HongHoldingMember 2023-09-30 0001722731 FDCT:AlchemyPrimeHoldingsLtdMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:AlchemyPrimeHoldingsLtdMember 2026-03-31 0001722731 FDCT:GopeSKundnaniMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:GopeSKundnaniMember 2026-03-31 0001722731 FDCT:MitchellMEaglsteinMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:MitchellMEaglsteinMember 2026-03-31 0001722731 FDCT:ImranFirozMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:ImranFirozMember 2026-03-31 0001722731 FDCT:FRHGroupMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:FRHGroupMember 2026-03-31 0001722731 FDCT:WilliamBBarnettMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:WilliamBBarnettMember 2026-03-31 0001722731 FDCT:SusanEEaglsteinMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:SusanEEaglsteinMember 2026-03-31 0001722731 FDCT:NickyGKundnaniMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:NickyGKundnaniMember 2026-03-31 0001722731 FDCT:OfficersAndDirectorsMember us-gaap:SeriesBPreferredStockMember 2026-01-01 2026-03-31 0001722731 us-gaap:SeriesBPreferredStockMember FDCT:OfficersAndDirectorsMember 2026-03-31 0001722731 FDCT:ADSMember 2025-01-01 2025-03-31 0001722731 FDCT:AMLMember 2025-01-01 2025-03-31 0001722731 FDCT:APLMember 2025-01-01 2025-03-31 0001722731 FDCT:ATECHMember 2025-01-01 2025-03-31 0001722731 FDCT:ADSMember 2026-01-01 2026-03-31 0001722731 FDCT:AMLMember 2026-01-01 2026-03-31 0001722731 FDCT:APLMember 2026-01-01 2026-03-31 0001722731 FDCT:ATECHMember 2026-01-01 2026-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares FDCT:Days iso4217:EUR iso4217:GBP xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended March 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File No. 000-56338

 

FDCTECH, INC.

(Exact name of the small business issuer as specified in its charter)

 

Delaware   81-1265459

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

200 Spectrum Center Drive, Suite 300

Irvine, CA 92618

(Address of principal executive offices)

 

(877) 445-6047

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
         

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

The number of shares of Common Stock, $0.0001 par value, of the registrant outstanding on May 15, 2026, was 423,084,729.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
PART I.
     
  Item 1. Financial Statements. F-1
     
  Consolidated Balance Sheets as of March 31, 2026 (Unaudited), and December 31, 2025 (Audited) F-2
     
  Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-3
     
  Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-4
     
  Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-5
     
  Notes to Unaudited Consolidated Financial Statements F-6
     
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 4
     
  Item 3. Quantitative and Qualitative Disclosures About Market Risks. 13
     
  Item 4. Controls and Procedures 13
     
PART II.
     
  Item 1. Legal Proceedings. 14
     
  Item 1A. Risk Factors. 14
     
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 14
     
  Item 3. Defaults Upon Senior Securities. 14
     
  Item 4. Mine Safety Disclosures. 14
     
  Item 5. Other Information. 14
     
  Item 6. Exhibits. 14
     
SIGNATURES 15
     
EXHIBIT INDEX 16

 

2

 

 

FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (“Form 10-Q”) contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue, or other financial items; any statements of the plans, strategies, and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and inherent risks and uncertainties.

 

Forward-looking statements may include the words “may,” “could,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “desire,” “goal,” “should,” “objective,” “seek,” “plan,” “strive” or “anticipate,” as well as variations of such words or similar expressions, or the negatives of these words. These forward-looking statements present our estimates and assumptions only as of the date of this Form 10-Q. Except for our ongoing obligation to disclose material information as required by the federal securities laws, we do not intend to and undertake no obligation to update any forward-looking statement. We caution readers not to place undue reliance on any such forward-looking statements. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes will likely vary materially from those indicated.

 

3

 

 

PART I.

 

Item 1. Financial Statements.

 

FDCTECH, INC.

 

Index to Consolidated Financial Statements

 

  Pages
   
Consolidated Balance Sheets as of March 31, 2026 (Unaudited), and December 31, 2025 (Audited) F-2
   
Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-3
   
Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-4
   
Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025 (Unaudited) F-5
   
Notes to the Consolidated Financial Statements F-6

 

F-1

 

 

FDCTECH, INC.

 

CONSOLIDATED BALANCE SHEETS

 

   March 31,
2026
   December 31,
2025
 
   (Unaudited)   (Audited) 
         
Assets          
Current assets:          
Cash  $36,891,541   $17,669,749 
Accounts receivable, net of allowance for doubtful accounts of $0 and $22,382, respectively   358,932    188,415 
Prepaid – current   345,612    353,089 
Related party receivable   30,154,645    37,477,356 
Total Current assets   67,750,730    55,688,609 
Prepaid – non-current   189,796    244,008 
Fixed assets, net   187,657    199,058 
Capitalized software, net   1,578,353    1,480,246 
Investment through subsidiary   34,510    36,062 
Accrued income   275,715    279,889 
Acquired intangible assets   1,250,397    1,326,062 
Other trade and tax receivable   187,508    2,803,041 
Fair value of trading positions for the firm, profit   72,386    1,183,873 
Right of use (lease)   668,214    530,348 
Total assets  $72,195,266   $63,771,196 
           
Liabilities and Stockholders’ Equity (Deficit)          
Current liabilities:          
Accounts payable  $502,087   $166,212 
Line of credit   266,926    111,352 
Accrued expenses, related party   997,259    532,287 
Business acquisition loan   2,350,000    2,350,000 
Related party advances   3,296,890    29,197,470 
Customer funds   28,339,255    5,813,888 
Operating lease liability, current   186,158    501,236 
Other current liabilities   1,642,601    2,132,993 
Total Current liabilities   37,581,176    40,805,438 
Deferred tax liabilities   372,339    377,975 
SBA loan – non-current   103,552    105,678 
Operating lease liability – non-current   482,056    29,112 
Accrued interest – non-current   43,650    42,396 
Total liabilities   38,582,773    41,360,599 
Commitments and Contingencies (Note 8)   -    - 
           
Stockholders’ Equity (Deficit):          
Series A Preferred stock, par value $0.0001, 10,000,000 shares authorized, 4,500,000          
and 4,500,000 issued and outstanding, as of March 31, 2026 and December 31, 2025   450    450 
Series B Preferred stock, par value $0.0001, 3,000,000 shares authorized,          
2,371,844 and 2,371,844 issued and outstanding, as of March 31, 2026 and December 31, 2025   237    237 
Common stock, par value $0.0001, 750,000,000 shares authorized; 423,084,729 and          
423,084,729 shares issued and outstanding, as of March 31, 2026 and December 31, 2025   42,308    42,308 
Additional paid-in capital   28,199,590    23,555,937 
Subscription receivable   (8,000,000)   (8,000,000)
Additional paid-in capital, Series B Preferred stock   3,344,063    3,344,063 
Accumulated other comprehensive income (loss)   (2,427)   313,484 
Accumulated surplus (deficit)   9,984,473    3,120,795 
Total FDCTech, Inc. stockholders’ equity (deficit)   33,568,694    22,377,274 
Noncontrolling interest   43,799    33,323 
Total liabilities and stockholders’ equity (deficit)  $72,195,266   $63,771,196 

 

See accompanying notes to the financial statements.

 

F-2

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

   March 31, 2026   March 31, 2025 
   Three Months Ended 
   March 31, 2026   March 31, 2025 
   (Unaudited)   (Restated, Unaudited) 
         
Revenues          
Technology & software  $1,639,222   $813,747 
Wealth management   1,565,852    1,534,852 
Brokerage (Trading)   12,009,418    3,628,349 
Total revenue  $15,214,492   $5,976,948 
Cost of sales          
Technology & software   -    184,284 
Wealth management   1,435,250    1,349,827 
Brokerage (Trading)   2,148,088    1,583,278 
Total cost of sales   3,583,338    3,117,389 
Gross Profit  $11,631,154   $2,859,559 
Operating expenses:          
General and administrative   4,324,900    2,140,270 
Sales and marketing   404,302    276,204 
Depreciation   46,643    38,832 
Total operating expenses  $4,775,845   $2,455,306 
Operating income (loss)   6,855,309    404,253 
Other income (expense):          
Other interest income (expense)   132,492    4,483 
Other income (expense)   (117,881)   (304,188)
Total other income (expense)  $14,611   $(299,705)
Income (loss) before provision for income taxes   6,869,920    104,548 
Provision for income tax   -   $-
Net income (loss)  $6,869,920   104,548 
           
Net income (loss) per common share, basic and diluted  $0.016   $0.000 
Weighted average number of common shares outstanding basic and diluted   423,084,729    422,229,173 
           
Other comprehensive income (loss):          
Change in foreign currency translation  $2,427  $(140,137)
Total other comprehensive income (loss)   2,427  (140,137)
Total comprehensive income (loss) 

$

6,872,347    (35,589)
Comprehensive income (loss) attributable to noncontrolling interests   6,242   $(13,498)
Comprehensive income (loss) attributable to FDCTech stockholders  $6,866,105   $(22,091)

 

See accompanying notes to the financial statements

 

F-3

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

 

   Shares   Amount   Shares   Amount   Capital   AOCI   Receivable   (Deficit)   Equity 
   Preferred Stock   Common Stock   Additional Paid-in       Subscription   Accumulated Surplus   Total
Stockholders’
 
   Shares   Amount   Shares   Amount   Capital   AOCI   Receivable   (Deficit)   Equity 
                                     
Three months ended March 31, 2025 (Restated)                                             
Balance, December 31, 2024   6,861,844    686    390,584,729    39,058    17,009,409    (53,270)   -    (2,563,620)   14,432,263 
Common stock issued for services   -    -    32,000,000    3,200    32,000    -    -    -    35,200 
Series B issuances at $1.41 per share   10,000    1    -    -    14,099    -    -    -    14,100 
Change in APIC due to common control   -    -    -    -    882,771    -    -    -    882,771 
FX gain (loss)   -    -    -    -    -    193,407    -    

(7,812

)   185,595 
Net (income) loss attributable to noncontrolling interest   -    -    -    -    -    -    -    (13,498)   (13,498)
Net income (loss)   -    -    -    -    -    -    -    104,548    104,548 
Balance, March 31, 2025   6,871,844    687    422,584,729    42,258    17,938,279    140,137    -    (2,480,382)   15,640,979 
                                              
Three months ended March 31, 2026                                             
Balance, December 31, 2025   6,871,844    687    423,084,729    42,308    26,900,000    313,484    (8,000,000)   3,120,795    22,377,274 
Change in APIC due to common control   -    -    -    -    4,643,653    -    -    -    4,643,653 
FX gain (loss)   -    -    -    -    -    (315,911)   -    -    (315,911)
Net (income) loss attributable to noncontrolling interest   -    -    -    -    -    -    -    (6,242)   

(6,242

)
Net income (loss)   -    -    -    -    -    -    -    6,869,920    6,869,920 
Balance, March 31, 2026   6,871,844    687    423,084,729    42,308    31,543,653    (2,427)   (8,000,000)   9,984,473    33,568,694 

 

See accompanying notes to the financial statements

 

F-4

 

 

FDCTECH, INC.

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

   March 31, 2026   March 31, 2025 
   Three Months Ended 
   March 31, 2026   March 31, 2025 
   (Unaudited)   (Restated, Unaudited) 
         
Operating Activities:          
Net income (loss)  $6,869,920   $104,548 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Less: Net income attributable to noncontrolling interest   (6,242)   (13,498)
Depreciation   46,643    38,832 
Common stock issued for services   -    49,299 
Series B Preferred issued for services   -    1 
Fixed assets, net   (35,242)   25,425 
Acquired intangible assets   75,665    (24,908)
Change in assets and liabilities:          
Gross accounts receivable   (170,517)   (16,320)
Prepaid   61,689   (186,449)
Related party receivable   7,322,711    (1,446,098)
Accounts payable   335,875    235,223 
Other current liabilities   (490,392)   (4,434,429)
Accrued interest   1,254    67 
Customer funds   22,525,367    5,926,493 
Fair value of trading position, net   1,111,487    143,164 
Operating lease   137,866    (43,713)
Deferred taxes   (5,636)   15,114 
Tax receivable by subsidiaries   2,615,533    (7,612)
Accrued income   4,174    (250,316)
Right of use of assets (lease)   (137,866)   43,713 
Accrued expenses, related party   464,972    7,500 
Net cash provided by (used in) operating activities  $40,727,261   $166,036 
           
Investing Activities:          
Capitalized software   (98,107)   (54,234)
Investment through subsidiary   1,552    - 
Business acquisition seller’s note   -    - 
Changes in paid-in capital, common control   4,643,653    882,771 
Net cash provided by (used in) investing activities  $4,547,098   $828,537 
           
Financing Activities:          
Borrowing from (payments to) line of credit   155,574    110,463 
Net proceeds from cares act – paycheck protection program   -    (3,272)
Net proceeds from SBA loan   (2,126)   (2,127)
Related party advances   (25,900,580)   932,932 
Noncontrolling interest   10,476    (10,433)
Net cash provided by (used in) financing activities  $(25,736,656)  $1,027,563 
Effect of exchange rate changes on cash   (315,911)   193,407 
           
Net increase (decrease) in cash   19,221,792    2,215,543 
Cash at beginning of the period   17,669,749    24,781,389 
Cash at end of the period  $36,891,541   $26,996,932 

 

See accompanying notes to the financial statements

 

F-5

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS

 

Organization and General

 

FDCTech, Inc. (“FDCTech,” “the Company,” “we,” “us,” or “our”) is a financial technology company incorporated in the State of Delaware, United States of America, and is publicly traded on the OTC markets under the ticker symbol OTC: FDCT. The Company is a fully reporting public company subject to the reporting obligations of the Securities Exchange Act of 1934, as amended.

 

The Company was founded in January 2016 as a back-office technology solution provider to the over-the-counter (“OTC”) brokerage and financial services industries. Through a series of strategic acquisitions, the Company has evolved into a diversified global financial technology platform. These acquisitions include AD Advisory Services Pty Ltd. (2021), Alchemy Markets Ltd. (2022–2023), Alchemy Prime Limited (2023), and Alchemy International Ltd. (2025), collectively expanding the Company’s operational footprint across Australia, Malta, the United Kingdom, Cyprus, Seychelles, and Mauritius.

 

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries (collectively, the “Company”) for the three months ended March 31, 2026. All intercompany balances and transactions have been eliminated in consolidation.

 

Corporate Structure and Subsidiaries

 

FDCTech, Inc. serves as the parent holding company. The following table presents the Company’s consolidated subsidiaries as of March 31, 2026:

 

Subsidiary   Ownership   Jurisdiction   Primary Business   Markets Served   Technology
AD Advisory Services Ltd. (ADS)   51.00%   Australia   Wealth Management   Australia   Third-party software
Alchemy Markets Ltd. (AML)   100.00%   Malta   FX, CFDs, Stocks, Bonds   Europe (excl. UK)   Condor Trading & Third-party
Alchemy Prime Ltd. (APL)   100.00%   United Kingdom   FX, CFDs   United Kingdom   Condor Trading & Third-party
Alchemytech Ltd. (ATECH)   100.00%   Cyprus   Technology Services   Europe   Condor Trading
Alchemy International Ltd. (AIL)   100.00%   Seychelles   FX, CFDs   Asia   Condor Trading & Third-party
Xoala Asia (XOA)   100.00%   Mauritius   Payment Intermediary Services   Asia   Third-party
Prime Intermarket Group Eurasia (PIG)   100.00%   Mauritius   FX, CFDs   Asia   Condor Trading & Third-party

 

The Company consolidates all subsidiaries in which it holds a controlling financial interest. AD Advisory Services Ltd. (ADS) is consolidated as a majority-owned subsidiary (51.00% ownership), with the remaining 49.00% recognized as a noncontrolling interest in the consolidated balance sheet and statements of operations. All other subsidiaries are wholly owned (100%) and fully consolidated.

 

F-6

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS (continued)

 

Nature of Operations

 

The Company operates through four complementary business segments, as follows:

 

(a) Margin Brokerage

 

Through Alchemy Markets Ltd. (Malta, regulated by the Malta Financial Services Authority (“MFSA”), Alchemy Prime Limited (United Kingdom, regulated by the Financial Conduct Authority (“FCA”)), and Alchemy International Ltd. (Seychelles, regulated by the Financial Services Authority (“FSA”)), the Company provides multi-asset online trading services—including foreign exchange (“FX”), contracts for difference (“CFDs”), equities, commodities, and digital assets—to retail and institutional clients globally.

 

(b) Wealth Management

 

Through AD Advisory Services Pty Ltd. (Australia, regulated by the Australian Securities and Investments Commission (“ASIC”)), the Company operates a wealth management business with 28 financial advisors collectively managing and advising on approximately $530 million in funds under advice as of December 31, 2025. This segment provides licensing solutions and financial planning services to independent financial advisors operating under the Company’s Australian Financial Services license.

 

(c) Technology and Software Development

 

Through FDCTech, Inc. and Alchemytech Ltd. (Cyprus), the Company develops, licenses, and supports its proprietary Condor Trading Technology suite, which includes the Condor Pro Multi-Asset Trading Platform and the Condor Risk Management back-office system. This technology supports multi-asset trading, risk management, and pricing across FX, equities, commodities, and digital assets and is utilized both internally across the Company’s brokerage subsidiaries and licensed to third-party brokerage firms.

 

(d) Payment Intermediary Services

 

Through Xoala Asia (Mauritius, licensed by the Financial Services Commission (“FSC”)), the Company is developing a payment gateway, merchant acquiring, and cross-border payment capabilities to complement its brokerage and wealth management operations. As of March 31, 2026, this segment remains in the development stages and has not yet generated material revenue.

 

Regulatory Environment

 

The Company’s brokerage and wealth management subsidiaries operate under licenses and regulatory oversight from multiple international financial regulatory authorities, including the MFSA (Malta), FCA (United Kingdom), FSA (Seychelles), ASIC (Australia), and FSC (Mauritius). The Company is required to maintain minimum regulatory capital levels and comply with ongoing reporting, conduct-of-business, and anti-money-laundering obligations in each of its operating jurisdictions. Regulatory compliance and capital adequacy are monitored by management on an ongoing basis.

 

Going Concern Consideration

 

These consolidated financial statements have been prepared on a going concern basis, which assumes the Company will continue its operations for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. Management has evaluated the Company’s ability to continue as a going concern in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements—Going Concern. The Company’s assessment of going concern, including any identified conditions or events that may raise substantial doubt, and management’s plans to mitigate such conditions, are further described in Note 2.

 

Fiscal Year

 

The Company’s fiscal year ends on December 31. The consolidated financial statements presented herein are for the year ended December 31, 2025.

 

Board of Directors

 

At present, the Company has four members of the Board of Directors. Mitchell M. Eaglstein is the acting Chairman of the Company. Mitchell M. Eaglstein and Imran Firoz are the company’s executive directors and officers. Gope S. Kundnani is considered an executive director by owning at least 10% of the Company’s stock. Jonathan Baumgart is an independent director under NYSE and NASDAQ listing standards.

 

Mitchell M. Eaglstein and Imran Firoz have been Executive Directors of the Company since January 21, 2016.

 

On June 15, 2021, the Company appointed Jonathan Baumgart as the Director of the Company.

 

On September 30, 2022, the Company appointed Gope S. Kundnani as the Director of the Company.

 

F-7

 

 

NOTE 1. BUSINESS DESCRIPTION AND NATURE OF OPERATIONS (continued)

 

Recent Acquisitions and Developments

 

Acquisition of Alchemy International Ltd.

 

On November 11, 2025, the Company finalized the acquisition of Alchemy International Ltd., a Seychelles-licensed securities dealer regulated under license number SD136 by the Financial Services Authority (FSA). The change of control was approved on October 29, 2025, by the FSA.

 

Establishment of Xoala Asia

 

On November 6, 2025, Xoala Asia was granted a Payment Intermediary Services license by the Financial Services Commission of Mauritius (license no. GB25204956). Management is in the process of implementing the compliance, technology, and operating framework required by the FSC (including AML/CFT, safeguarding of client funds where applicable, operational resilience, data protection, and reporting). There has been no activity in Xoala Asia for the three months ending March 31, 2026.

 

Establishment of Prime Intermarket Group Eurasia

 

Effective January 1, 2026, we commenced start-up work under Prime Intermarket Group Eurasia (FXPIG), a Mauritius-based private limited company under Section 24 of the Companies Act. The company was originally established in May 2025, with no operations.

 

Recent Corporate Actions

 

On September 4, 2025, our Board of Directors unanimously approved, and we obtained the written consent of holders of a majority of our voting power for, corporate actions to (i) amend our Certificate of Incorporation to increase the number of authorized shares of common stock from 500,000,000 to 750,000,000 and the number of authorized shares of preferred stock from 10,000,000 to 15,000,000; and (ii) authorize our Board of Directors, in its discretion, to amend our Certificate of Incorporation not later than June 30, 2026, to effect a reverse stock split of all outstanding shares of common stock in a ratio of not less than 1-for-10 and not more than 1-for-100, to be determined by the Board. The amendment effecting the increase in authorized shares has been filed with the Secretary of State of the State of Delaware and is in effect as of March 31, 2026.

 

Certificate of Designation of Series B Convertible Preferred Stock

 

On March 24, 2026, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series B Certificate of Designation designates 3,000,000 shares of the Company’s authorized preferred stock (par value $0.0001 per share) as “Series B Convertible Preferred Stock” and establishes the rights, preferences, privileges, and restrictions of such shares, including a default conversion rate of one hundred (100) shares of Common Stock for each one share of Series B Convertible Preferred Stock, with the conversion rate adjustable by the Board of Directors within a range of between one hundred (100) and ten (10) shares of Common Stock for each one share of Series B Convertible Preferred Stock if the Company completes a public offering of $10,000,000 or more that includes an uplisting of the Common Stock to The Nasdaq Stock Market or the New York Stock Exchange. The principal terms of the Series B Convertible Preferred Stock are described further in Note 9.

 

U.S.-Iran Military Conflict

 

On February 28, 2026, the United States and Israel launched coordinated joint military strikes against Iran, targeting military, governmental, and nuclear-related sites. Iran subsequently responded with missile and drone attacks targeting Israel, U.S. military bases in the region, and Gulf state infrastructure, and has sought to restrict commercial shipping traffic through the Strait of Hormuz. The Company maintains a sales office in Tel Aviv, Israel. As of the date of this report, the Tel Aviv office has not experienced any material disruption to its operations as a direct result of the conflict, and the safety of the Company’s personnel located there has not been compromised. The Company’s operating subsidiaries are located in the United Kingdom, Malta, Cyprus, Australia, Seychelles, and Mauritius, none of which are in the directly affected region. The conflict has contributed to significant volatility in global energy prices and financial markets, which may affect client trading volumes, foreign currency exchange rates, and the general business environment in which the Company operates. As of the date of this report, the Company has not experienced any material disruption to its business operations as a direct result of the conflict.

 

Ukraine-Russia Conflict

 

The geopolitical situation in Eastern Europe intensified on February 24, 2022, with Russia’s invasion of Ukraine. By the end of August 2022, the Company closed its technical support and development office in Russia and relocated its personnel to Turkey, currently considered a neutral zone. No individual associated with the Company is on the Specially Designated Nationals (SDN) and Blocked Persons list. As of the date of this report, there has been no disruption to our operations.

 

Description of Company’s Securities to be Registered

 

Effective September 3, 2021, the Company’s description of its common stock, par value $0.0001 per share, to be registered hereunder is contained under the heading “Description of Securities” in the Company’s Registration Statement on Form S-1 (File No. 333-221726), as initially filed with the Securities and Exchange Commission on November 22, 2017, as subsequently amended (the “Registration Statement”). Since the Registration Statement filing, the Company has made all required filings pursuant to Section 15(d) and has continued to file all reports voluntarily.

 

As of March 31, 2026, the Company had 423,084,729 shares of Common Stock, 4,500,000 shares of Series A Preferred Stock, and 2,371,844 shares of Series B Preferred Stock issued and outstanding. Holders of Series A Preferred Stock are entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action and have no right to convert into the Company’s common stock. The Series B Preferred Stock is non-dilutive and is not subject to stock splits or any other adjustments to the Company’s common stock. Each share of Series B Preferred Stock can be converted into 100 shares of the Company’s common stock at any time by the holder of such shares, subject to the conversion-rate adjustment described above in connection with a qualifying public offering. Series B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action.

 

F-8

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of FDCTech, Inc. and its wholly owned subsidiary. We have eliminated all intercompany balances and transactions. The Company has prepared the consolidated financial statements consistent with the Company’s accounting policies in its financial statements. The Company has measured and presented the Company’s consolidated financial statements in US Dollars, which is the currency of the primary economic environment in which the Company operates (also known as its functional currency).

 

Consolidated Financial Statement Preparation and Use of Estimates

 

The Company prepared the consolidated financial statements according to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosures at the date of the consolidated financial statements, as well as the reported amounts of revenue and expenses during the periods presented. Estimates include revenue recognition, the allowance for doubtful accounts, website and internal-use software development costs, recoverability of intangible assets with finite lives, and other long-lived assets. Actual results could materially differ from these estimates.

 

Restatement of Previously Issued Financial Statements

 

On August 5, 2025, the Company identified an error in the preparation of its condensed consolidated financial statements for the three months ended March 31, 2025. Specifically, the Company erroneously included the results of operations of its subsidiary, APL, for a prior period rather than for the current quarter. As a result, revenue, cost of sales, and certain operating expenses were overstated, and other related line items in the condensed consolidated balance sheets, statements of operations, statements of stockholders’ equity, and statements of cash flows were misstated.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with three months or less of original maturities. The Company maintains its cash balances at multiple financial institutions, both domestic and foreign. For US financial institutions, the balances do not exceed Federal Deposit Insurance Corporation (FDIC) limits as of March 31, 2026. However, as of December 31, 2025, the majority of the cash balance was held with non-FDIC financial institutions in Malta, the UK, and other countries. As of March 31, 2026, and December 31, 2025, the Company had $36,891,541 and $17,669,749 in cash and cash equivalents held at the financial institution.

 

F-9

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Accounts Receivable

 

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company’s accounts receivable arise principally from brokerage commissions, rebates, and technology service fees earned from counterparties and customers in the ordinary course of business. Receivables are generally short-term in nature and are typically settled within thirty days of the invoice date.

 

The Company evaluates the collectability of its accounts receivable on an ongoing basis and maintains an allowance for doubtful accounts at a level management believes to be sufficient to absorb estimated losses inherent in the receivable portfolio as of the balance sheet date. The allowance is determined based on a review of specific accounts considered to be at risk, taking into consideration the age of the receivable, the financial condition and payment history of the counterparty, current economic conditions, and other relevant factors. Account balances are charged against the allowance after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. Recoveries of receivables previously written off are recorded as a reduction to bad debt expense in the period the amounts are received.

 

As of March 31, 2026 and December 31, 2025, accounts receivable were $358,932 and $188,415, respectively, in each case net of an allowance for doubtful accounts of $0 and $22,382. No provision for doubtful accounts was recorded during the three months ended March 31, 2026 or March 31, 2025, and management believes the allowance is adequate to cover expected credit losses as of March 31, 2026.

 

Sales, Marketing, and Advertising

 

The Company recognizes sales, marketing, and advertising expenses when incurred.

 

The Company incurred $404,302 and $276,204 in sales, marketing, and advertising costs (“sales and marketing”) for the three months ended March 31, 2026, and 2025, respectively. Sales and marketing costs primarily consisted of travel costs for tradeshows and customer meetings, online marketing on industry websites, press releases, and public relations activities. The increase in sales and marketing expenses is primarily attributable to expanded promotional and marketing activities supporting the Company’s broader brokerage and technology client base during the three months ended March 31, 2026.

 

Sales, marketing, and advertising expenses represented approximately 2.66% and 4.62% of revenues for the three months ended March 31, 2026, and 2025, respectively.

 

Revenue Recognition

 

On January 1, 2019, the Company adopted ASU 2014-09 Revenue from Contracts with Customers. The majority of the Company’s revenues come from two contracts – IT support and maintenance (‘IT Agreement’) and software development (‘Second Amendment’) that fall within the scope of ASC 606.

 

The Company recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those goods or services as per the contract with the customer. As a result, the Company accounts for revenue contracts with customers by applying the requirements of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (Topic 606), which includes the following steps:

 

  Identify the contract or contracts and subsequent amendments with the customer.
  Identify all the performance obligations in the contract and subsequent amendments.
  Determine the transaction price for completing performance obligations.
  Allocate the transaction price to the performance obligations in the contract.
  Recognize the revenue when, or as, the Company satisfies a performance obligation.

 

The Company adopted ASC 606 using the modified retrospective method applied to all contracts not completed as of January 1, 2019. The Company presents results for reporting periods beginning after January 1, 2019, under ASC 606, while prior period amounts are reported following legacy GAAP. In addition to the above guidelines, the Company also considers implementing guidance on warranties, customer options, licensing, and other topics. The Company considers revenue collectability, methods for measuring progress toward complete satisfaction of a performance obligation, warranties, customer options for additional goods or services, non-refundable upfront fees, licensing, customer acceptance, and other relevant categories.

 

The Company accounts for a contract when the Company and the customer (‘parties’) have approved of the contract and are committed to performing their respective obligations. Each party can identify its rights, obligations, and payment terms; the contract has commercial substance. The Company will collect all of the considerations. Revenue is recognized when performance obligations are satisfied by transferring control of the promised service to a customer. The Company fixes the transaction price for goods and services at contract inception. The Company’s standard payment terms are net 30 days and, in some cases, due upon receipt of the invoice.

 

F-10

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The Company considers the change in scope, price, or both as contract modifications. The parties describe contract modification as a change order, a variation, or an amendment. A contract modification exists when the parties approve a modification that either creates new or changes existing enforceable rights and obligations. The Company assumes a contract modification by oral agreement or implied by the customer’s customary business practice when agreed in writing. If the parties to the contract have not approved a contract modification, the Company continues to apply the existing contract’s guidance until the contract modification is approved. The Company recognizes contract modification in various forms –partial termination, an extension of the contract term with a corresponding price increase, adding new goods or services to the contract, with or without a corresponding price change, and reducing the contract price without a change in goods/services promised.

 

At contract inception, the Company assesses the solutions or services, or bundles of solutions and services, obligated in the contract with a customer to identify each performance obligation within the contract and then evaluate whether the performance obligations are capable of being distinct and distinct within the context of the agreement. Solutions and services that are not capable of being distinct and distinct within the contract context are combined and treated as a single performance obligation in determining the allocation and recognition of revenue. For multi-element transactions, the Company allocates the transaction price to each performance obligation on a relative stand-alone selling price basis. The Company determines the stand-alone selling price for each item at the transaction’s inception, involving these multiple elements.

 

Since January 21, 2016 (‘Inception’), the Company has derived its revenues mainly from consulting services, technology solutions, and customized software development. The Company recognizes revenue when it has satisfied a performance obligation by transferring control over a product or delivering a service to a customer. We measure revenue based on the consideration outlined in an arrangement or contract with a customer.

 

F-11

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

The Company’s standard performance obligations include the following:

 

Performance Obligation   Types of Deliverables   When Performance Obligation is Typically Satisfied
Consulting Services   Consulting related to Start-Your-Own-Brokerage (“SYOB”), Start-Your-Own-Prime Brokerage (“SYOPB”), Start-Your-Own-Crypto Exchange (“SYOC”), FX/OTC liquidity solutions and lead generations.   The Company recognizes the consulting revenues when the customer receives services over the contract length. If the customer pays the Company in advance for these services, the Company records such payment as deferred revenue until the Company completes the services.
         
Technology Services   Licensing of Condor Risk Management Back Office (“Condor Risk Management”), Condor FX Pro Trading Terminal, Condor Pricing Engine, Crypto Trading Platform (“Crypto Web Trader Platform”), and other cryptocurrency-related solutions.   The Company recognizes ratably over the contractual period that the services are delivered, beginning on the date such service is made available to the customer. Licensing agreements are typically one year in length with an option to cancel by giving notice; customers have the right to terminate their agreements if the Company materially breaches its obligations under the agreement. Licensing agreements do not provide customers the right to take possession of the software. The Company charges the customers a set-up fee for installing the platform, and implementation activities are insignificant and not subject to a separate fee.
         
Software Development   Design and build development software projects for customers, where the Company develops the project to meet the design criteria and performance requirements as specified in the contract.   The Company recognizes the software development revenues when the Customer obtains control of the deliverables as stated in the Statement-of-Work contract.

 

The Company assumes that the goods or services promised in the existing contract will be transferred to the customer to determine the transaction price. The Company believes that the contract will not be canceled, renewed, or modified; therefore, the transaction price includes only those amounts to which the Company has rights under the present contract. For example, suppose the Company enters a contract with a customer with an original term of one year and expects the customer to renew it for a second year. In that case, the Company will determine the transaction price based on the initial one-year period. When choosing the transaction price, the company first identifies the fixed consideration, including non-refundable upfront payment amounts.

 

To allocate the transaction price, the Company gives the amount that best represents the consideration that the entity expects to receive for transferring each promised good or service to the customer. The Company allocates the transaction price to each performance obligation identified in the contract on a relatively standalone selling price basis to meet the allocation objective. In determining the standalone selling price, the Company uses the best evidence of the stand-alone selling price that the Company charges to similar customers in similar circumstances. The Company sometimes uses the adjusted market assessment approach to determine the standalone selling price. It evaluates the market in which it sells the goods or services and estimates the price that customers in that market would pay for those goods or services when sold separately.

 

The Company recognizes revenue when or as it transfers the promised goods or services into the contract. The Company considers the “transfers” of the promised goods or services when the customer obtains control of the goods or services. The Company believes a customer “obtains control” of an asset when it can directly use and substantially obtain all the remaining benefits from an asset. The Company recognizes deferred revenue related to services it will deliver within one year as a current liability. The Company presents deferred revenue related to services that the Company will provide more than one year into the future as a non-current liability.

 

According to the contract’s terms and conditions, the Company invoices the customer at the beginning of the month for the month’s services. The invoice amount is due upon receipt. The Company recognizes the revenue at the end of each month, equal to the invoice amount.

 

F-12

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Wealth Management

 

AD Advisory Services Pty (ADS), the Company’s wealth management revenue, primarily consists of advisory revenue, commission revenue from insurance products, fees to prepare the statement of advice, rebalancing portfolio, and other financial planning activities. ADS is authorized and regulated by the Australian Securities & Investments Commission (ASIC) to conduct licensing activities in Australia.

 

ASC 606 establishes a five-step model for revenue recognition aimed at enhancing comparability and transparency across entities, industries, and capital markets. The Company only recognizes revenue that reflects the transfer of promised goods or services to customers in exchange for the consideration to which the entity expects to be entitled.

 

For ADS, a contract is an agreement between ADS and a client that creates enforceable rights and obligations, encompassing advisory services, insurance product commissions, and other financial planning activities. Contracts may be written, oral, or implied by customary business practices and are identified when both parties approve the agreement; each party can identify rights regarding the goods or services to be transferred, establish payment terms, the contract has commercial substance, and collection of payment is probable.

 

A performance obligation is a promise in a contract to transfer a distinct good or service to the Customer. For ADS, performance obligations may include:

 

  Providing ongoing financial advisory services,
  Preparing statements of advice,
  Executing portfolio rebalancing,
  Facilitating the purchase of insurance products, and
  Offering other specialized financial and estate planning services.

 

We evaluate these services to determine if they are distinct, considering whether the Customer can benefit from the service on its own or with other readily available resources, and if the promise to transfer the service is separately identifiable from other promises in the contract.

 

The transaction price is the amount of consideration ADS expects to receive in exchange for transferring the promised goods or services to the Customer. These services include fixed fees, commissions from insurance products, and variable consideration for performance-based fees. ADS estimates the amount of variable consideration to which it will be entitled in a manner that reflects the likelihood and magnitude of a revenue reversal.

 

If a contract includes more than one performance obligation, ADS allocates the transaction price to each performance obligation based on its standalone selling price. When standalone selling prices are not directly observable, ADS estimates them using methods that may include cost-plus margin, market assessment, or residual approach, considering the Customer’s perceived value of each service.

 

ADS recognizes revenue when (or as) a performance obligation is satisfied, i.e., when the control of the promised good or service is transferred to the Customer. For ongoing services, revenue is recognized over time, reflecting the continuous transfer of services. For services performed at a specific point in time, revenue is recognized upon completion of the service. The pattern of revenue recognition is determined based on when the Customer obtains control of the promised good or service, which for advisory services is typically throughout the contract, and for transaction-based services (like insurance commissions or fees for specific planning activities), is at the point in time when the transaction is executed, or the service is rendered. If we receive payments before services, we defer and recognize them as revenue when we are satisfied with our performance obligation. Advisory revenue includes fees charged to clients in advisory accounts for which we are the licensed investment advisor. We bill advisory fees weekly.

 

F-13

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Investment and Margin Brokerage Business

 

Alchemy Markets Ltd (Alchemy Malta) and Alchemy Prime Ltd (Alchemy UK) are providers of trading services and solutions specializing in over-the-counter (“OTC”) and exchange-traded markets for European markets. Malta Financial Services Authority (MFSA) regulates Alchemy Malta with authorized countries, including Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Liechtenstein, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden. The Financial Conduct Authority (FCA) regulates Alchemy UK in authorized countries, including England, Scotland, Wales, and Northern Ireland.

 

The Company operates its brokerage business in two segments: retail and institutional (“clients” or “customers”). Through its retail and institutional segment, the Company provides its customers (individuals) around the world with access to a diverse range of global financial markets, including spot forex, precious metals, spread bets, and contracts for difference (“CFDs”) on currencies, commodities, indices, individual equities, cryptocurrencies, bonds, and interest rate products, as well as OTC options. The FCA defines a retail customer as a client who is not a professional or an eligible counterparty. A professional client is an entity that must be authorized or regulated to operate in the financial markets. According to the MFSA, a retail client is a client who is not a professional client or an eligible counterparty. A professional client possesses the knowledge, experience, and expertise to assess risks and make informed investment decisions.

 

We recognize Brokerage (Trading) revenue through the principal model following the guidance outlined in ASC 606, Revenues from Contracts with Customers. The Company primarily generates revenue through market-making and trading execution services for its clients, known as Brokerage (Trading) Revenues. The Brokerage (Trading) revenue is the Company’s largest source of revenue. Brokerage (Trading) revenue comprises revenue from the retail OTC business and the advisory business. OTC trading includes forex trading (“forex”), precious metals trading, CFDs, and spread betting (in markets that do not prohibit such transactions), as well as other financial products.

 

We realize gains or losses when we liquidate customer transactions. We revalue unrealized gains or losses on trading positions at prevailing market rates at the date of the balance sheet. We include them in Receivables from brokers, Payables to customers, and Payables to brokers on the Consolidated Balance Sheets. We record changes in net unrealized gains or losses in Brokerage (Trading) revenue on the Consolidated Statements of Operations and Comprehensive (Loss)/Income. We record Brokerage (Trading) revenue on a trade date basis.

 

We also generate business through an agency model by earning commissions and spreads for executing customer trades. We book these revenues on a trade-date basis. The Company acts as an agent concerning clearing trades, but is the principal on fees paid to introducing brokers. The Company does not assume any market-making risk related to customer trades in this business.

 

Net interest revenue consists primarily of the revenue generated by the Company’s cash and customer cash held at banks, as well as funds on deposit as collateral with the Company’s liquidity providers, less interest paid to the Company’s customers.

 

We record interest revenue and interest expense when earned and incurred, respectively.

 

F-14

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Concentrations of Credit Risk

 

Cash

 

Cash and cash equivalents include cash on hand, bank deposits, and other short-term, highly liquid investments with original maturities of three months or less at the date of acquisition. The Company maintains its cash balances at multiple financial institutions, both domestic and foreign. For balances held at U.S. financial institutions, such balances did not exceed Federal Deposit Insurance Corporation (“FDIC”) limits as of March 31, 2026. As of March 31, 2026, and December 31, 2025, the majority of the Company’s cash was held with non-FDIC financial institutions located in Malta, the United Kingdom, and other foreign jurisdictions. As of March 31, 2026, and December 31, 2025, the Company had $36,891,541 and $17,669,749 of cash and cash equivalents held at financial institutions, of which $21,651,699 and $15,258,896 were held at various liquidity providers, respectively.

 

Revenues

 

For the three months ended March 31, 2026, and 2025, the Company generated $15,214,492 and $5,976,948 in revenues, respectively, representing an increase of approximately 154.6% over the prior period. The Company’s revenues are derived from four operating segments: Margin Brokerage, Wealth Management, Technology and Software Development, and Payment Intermediary Services. The Payment Intermediary Services segment is in the start-up phase and did not generate revenues during the three months ended March 31, 2026, or 2025. The increase in revenues during the three months ended March 31, 2026 was primarily attributable to trading revenues generated by AIL.

 

Research and Development (R and D) Cost

 

The Company acknowledges that future benefits from research and development (R and D) are uncertain; therefore, we cannot capitalize on R and D expenditures. The GAAP accounting standards require us to expense all research and development expenditures as incurred. For the three months ended March 31, 2026, and 2025, the Company incurred R and D costs of $0 and $0. The R and D costs in the previous period were based on an evaluation of the technological feasibility costs of the Condor Investing and Trading App.

 

Legal Proceedings

 

The Company discloses a loss contingency if there is at least a reasonable possibility that a material loss has been incurred. The Company records its best estimate of loss related to pending legal proceedings when the loss is probable, and the amount can be reasonably estimated. The Company can reasonably estimate a range of losses with no best estimate in the range; the Company records the minimum estimated liability. As additional information becomes available, the Company assesses the potential liability related to pending legal proceedings, revises its estimates, and updates its disclosures accordingly. The Company’s legal costs associated with defending itself are recorded as expenses when incurred.

 

The Company and its subsidiaries are involved in the following legal proceedings:

 

Asher Alkoby, et al. v. FDCTech

 

This action is pending in the London Circuit Commercial Court under Claim Number LM-2024-000330 as of December 9, 2024. The claimants are Asher Alkoby and other former shareholders of Alchemy Markets Ltd. (“AML”), a Malta-incorporated broker that FDCTech purchased in June 2023. Following completion of the acquisition, the Company discovered that in 2019, the target company had anti-money laundering deficiencies and was fined by the Financial Intelligence Analysis Unit.

 

An external audit also revealed that the previous shareholders had taken loans from the company that were never repaid, resulting in the net capital of the company being lower than disclosed during negotiations. Based on these findings, FDCTech withheld the final payment to the sellers.

 

The claimants are seeking approximately $1.02 million in amounts they allege are owing under the Share Sale Agreement, which they are seeking to rectify to make it legally enforceable. The Company has counterclaimed for a declaration that the Share Sale Agreement is ineffective and unenforceable and seeks repayment of $915,000 paid to the sellers. On October 17, 2025, the Court granted the claimants permission to amend their claim to include a third claimant. The Company has prepared an Amended Defense and Counterclaim through Counsel, which was served May 9, 2025. A Costs and Case Management Conference took place on November 17, 2025, at which directions will be given to the trial, which will take place in November 2026.

 

FDCTech, Inc. v. Intelligenceline.com, Fintelegram.com, et al.

 

This action is pending in the Superior Court of California, County of Orange. FDCTech alleges that the defendants, through their websites Intelligenceline.com, Fintelegram.com, and Criticalintel.com, published false and defamatory statements accusing the Company of fraud, illegal conduct, and regulatory violations. The Company claims these statements have caused significant reputational and financial harm, including lost business opportunities. FDCTech further alleges that the defendants engaged in an extortion scheme by demanding payment for the removal of defamatory content.

 

The complaint asserts claims for defamation per se, defamation per quod, trade libel, and false light, seeking damages and injunctive relief. The complaint was filed in 2025 but had not yet been served as of December 31, 2025. A hearing took place on December 15, 2025, at the Company’s motion. FDCTech conducted the investigation and presented its findings during the management conference held on April 20, 2026. FDCTech is currently awaiting the court’s final judgment based on the outcome of the investigation.

 

Alchemy Markets Ltd. v. Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 104/2023)

 

This appeal is pending before the Court of Appeal (Inferior Jurisdiction) in Malta. On September 23, 2023, the Financial Intelligence Analysis Unit (FIAU) imposed an administrative penalty of €419,997 and a follow-up directive on Alchemy Markets Ltd. (formerly NSFX Limited), a subsidiary of the Company, based on a compliance examination conducted between November 25, 2019, and December 5, 2019. The examination occurred approximately four years prior to the decision and under a different ownership and control of the subsidiary.

 

The Company filed this appeal on October 19, 2023, challenging the decision-making process that led to the imposition of the penalty as well as the law on which it was based, asserting that the penalty is arbitrary and excessive, and claiming that certain aspects of the decision are unfounded both by law and in fact. The Company seeks to overturn the administrative penalty and the follow-up directive imposed by FIAU. The case is in the evidentiary production stage pertaining to the Company as appellant. On October 24, 2025, a hearing was held for the Company to continue presenting evidence. The Court scheduled an additional hearing for the FIAU to cross-examine the Company’s witnesses for February 2, 2026, and then for April 15 2026, heard before Madam Justice Rachel Montebello, following which the matter will be adjourned for final legal submissions.

 

F-15

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Alchemy Markets Ltd. v. L-Avukat tal-Istat u Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 159/2024)

 

This constitutional challenge is pending before the First Hall Civil Court (Constitutional Jurisdiction) in Malta and relates to the same September 23, 2023, FIAU decision described above. The Company filed this application on April 2, 2024, challenging: (i) the composition of the FIAU and its enabling law; (ii) the decision-making processes which allegedly breach the Company’s fundamental human right to a fair hearing; and (iii) that given the penal nature of the penalty, in breach of the Constitution of Malta, the Company was not adjudged by an independent court. The Company requests the Constitutional Court to set aside the FIAU decision in its entirety.

 

A first procedural hearing took place on May 7, 2024, and the Company has brought its evidence in support of the claim. The First Hall Civil Court (Constitutional Jurisdiction) has, in various instances, pronounced that administrative penalties being imposed by the FIAU are more akin to a penal sanction and that, therefore, subject persons should be afforded the full rights afforded to an accused under criminal law and has consistently quashed FIAU decisions on this basis. While these judgments are, in most part, subject to further appeal before the Constitutional Court of Appeal and have, in two instances, been overturned by the Constitutional Court of Appeal, the Company considers that the principles underpinning such previous judgments are applicable to the Company. The case remains pending as of January 21, 2026; the next hearing in the matter is set for January 28, 2026. On April 14, 2026, the Company submitted its final submissions before the Court. The Company is currently awaiting the Court’s final judgment following receipt and review of the FIAU’s final submissions.

 

The Company believes it has meritorious defenses and counterclaims in the above matters and intends to defend them vigorously. However, litigation is inherently uncertain, and the Company cannot predict the outcome of these proceedings with certainty.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets for impairment in accordance with FASB ASC 360, Property, Plant, and Equipment. Under the standard, long-lived assets are tested for recoverability whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. An impairment charge is recognized when the asset’s carrying value exceeds the fair value. There were no impairment charges as of March 31, 2026, and December 31, 2025.

 

Provision for Income Taxes

 

The provision for income taxes is determined using the asset and liability method. This method calculates deferred tax assets and liabilities based on the temporary differences between the consolidated financial statement and income tax bases of assets and liabilities using the enacted tax rates applicable each year.

 

The Company utilizes a two-step approach to recognizing and measuring uncertain tax positions (“tax contingencies”). The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount, exceeding 50%, that is likely to be realized upon ultimate settlement. The Company considers various factors when evaluating and estimating its tax positions and benefits, which necessitate periodic adjustments that may not accurately predict actual outcomes. The Company includes interest and penalties related to tax contingencies in the provision for income taxes in the consolidated statements of its operations. The Company’s management does not expect the total amount of unrecognized tax benefits to change significantly in the next twelve (12) months.

 

F-16

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Software Development Costs

 

In accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, software development costs, including expenses incurred to develop software that is sold, leased, or otherwise marketed, are capitalized after the establishment of technological feasibility, to the extent such costs are significant. The Company amortizes capitalized software development costs using the straight-line method over the estimated useful life of the application software. Costs incurred prior to the establishment of technological feasibility are expensed as research and development costs in the period incurred.

 

The Company established the technological feasibility of the Condor FX Back Office, the Condor Pro Multi-Asset Trading Platform Version, and the Condor Pricing Engine by the end of February 2016. The Company established the technological feasibility of the Digital Assets Web Trader Platform in February 2018 and of the Condor Investing and Trading App in January 2021. The Company estimates the useful life of each application software to be three (3) years.

 

The Company is continuing to develop the Condor Investing and Trading App and is currently capitalizing the costs associated with such development in accordance with the Company’s software development cost policy. Research and development costs incurred during the period ended September 30, 2022, were incurred in connection with evaluating the technological feasibility of the Robo Advice Platform, and research and development costs incurred during the period ended December 31, 2022, were incurred in connection with evaluating the technological feasibility of the Condor Investing and Trading App. There were no research and development costs incurred during the three months ended March 31, 2026, or 2025.

 

The Company also capitalizes major costs incurred during the application development stage for internal-use software in accordance with ASC 350-40, Internal-Use Software. Costs incurred during the preliminary project stage and post-implementation stage are expensed as incurred.

 

As of March 31, 2026, and December 31, 2025, capitalized software, net of accumulated amortization, was $1,578,353 and $1,480,246, respectively.

 

Property and Equipment, Net; Depreciation

 

Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets, which range from three3 to five years for computer equipment, furniture, and office equipment. Leasehold improvements, if any, are amortized over the shorter of the estimated useful life of the asset or the remaining lease term. Expenditures for repairs and maintenance that do not extend the useful life of the related asset are charged to expense as incurred, while expenditures that materially extend the useful life or improve the functionality of an asset are capitalized. Upon retirement or disposal, the cost and related accumulated depreciation are removed from the accounts, and any resulting gain or loss is recognized in the consolidated statements of operations.

 

As of March 31, 2026, and December 31, 2025, property and equipment, net of accumulated depreciation, were $187,657 and $199,058, respectively. Depreciation expense for the three months ended March 31, 2026, and 2025 was $46,643 and $38,832, respectively, and is included in operating expenses in the consolidated statements of operations.

 

Convertible Debentures

 

The cash conversion guidance in ASC 470-20, Debt with Conversion and Other Options, is considered when evaluating the accounting for convertible debt instruments, including certain convertible preferred stock classified as a liability, to determine whether the conversion feature should be recognized as a separate component of equity. The cash conversion guidance applies to all convertible debt instruments that, upon conversion, may be settled entirely or partially in cash or other assets where the conversion option is not bifurcated and separately accounted for pursuant to ASC 815.

 

If the conversion features of conventional convertible debt provide a conversion rate below market value, this feature is characterized as a beneficial conversion feature (“BCF”). The Company records BCF as a debt discount in accordance with ASC Topic 470-20, Debt with Conversion and Other Options. In such circumstances, the convertible debt is recorded net of the discount related to the Black-Scholes formula. The Company amortizes the discount to interest expense over the life of the debt using the effective interest method.

 

F-17

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Foreign Currency Translation and Re-measurement

 

The Company translates its foreign operations into US dollars in accordance with ASC 830, “Foreign Currency Matters.” Gains or losses resulting from translating the foreign currency financial statements are accumulated as a separate component of accumulated other comprehensive income (“AOCI”) in the Company’s stockholders’ equity and noncontrolling interests. Transaction gains and losses resulting from exchange rate changes on transactions denominated in currencies other than the functional currency of the applicable subsidiary are included in the Consolidated Statements of Income, within “Other (income) expense, net”, in the year in which the change occurs.

 

We have translated the local currency of ADS and AML in the Australian Dollar (AUD), Euro Dollar (EUR), and British Pound (GBP), respectively, into US$1.00 at the following exchange rates for the respective dates:

 

The exchange rate at the reporting end date:

 

   March 31,
2026
   December 31,
2025
 
USD: AUD  $1.4488    1.4993 
USD: EUR  $0.8652    0.8523 
USD: GBP  $0.7558    0.7436 

 

Average exchange rate for the period:

 

   Q1 2026   Q1 2025 
USD: AUD  $1.4396    1.5939 
USD: EUR  $0.8542    0.9507 
USD: GBP  $0.7420    0.7944 

 

ADS’ functional currency is AUD, and the reporting currency is the US dollar. AML’s functional currency is the EUR, and its reporting currency is the US dollar. APL’s functional currency is GBP, and its reporting currency is US dollars.

 

The Company translates its records into USD as follows:

 

  Assets and liabilities at the rate of exchange in effect at the balance sheet date
  Equities at the historical rate
  Revenue and expense items at the average rate of exchange prevailing during the period

 

F-18

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Fair Value

 

The Company uses current market values to recognize certain assets and liabilities at a fair value. The fair value is the estimated price at which the Company can sell the asset or settle a liability in an orderly transaction to a third party under current market conditions. The Company uses the following methods and valuation techniques for deriving fair values:

 

Market Approach – The market approach uses the prices associated with actual market transactions for similar or identical assets and liabilities to derive a fair value.

 

Income Approach – The income approach utilizes estimated future cash flows or earnings, adjusted by a discount rate that reflects the time value of money and the risk of not achieving the cash flows, to derive a discounted present value.

 

Cost Approach – The cost approach uses the estimated cost to replace an asset, adjusted for the obsolescence of the existing asset.

 

The Company ranks the fair value hierarchy of information sources from Level 1 (the best) to Level 3 (the worst). The Company uses these three levels to select inputs for valuation techniques:

 

Level I   Level 2   Level 3
Level 1 is a quoted price for an identical item in an active market on the measurement date. Level 1 is the most reliable evidence of fair value and is used whenever this information is available.   Level 2 is directly or indirectly observable inputs other than quoted prices. An example of a Level 2 input is a valuation multiple for a business unit, based on the sales, EBITDA, or net income of comparable companies.   Level 3 is an unobservable input. It may include the company’s data, adjusted for other reasonably available information. Examples of a Level 3 input are an internally generated financial forecast.

 

Basic and Diluted Income (Loss) per Share

 

The Company computes earnings per share in accordance with ASC 260, Earnings Per Share. Basic earnings per share (“EPS”) is computed by dividing net income (loss) attributable to the Company’s common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income (loss) attributable to the Company’s common stockholders by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding during the period. Common stock equivalents are excluded from the computation of diluted earnings per share when their effect would be antidilutive.

 

For the three months ended March 31, 2026, and 2025, the weighted average number of shares of common stock outstanding, used to compute both basic and diluted earnings per share, was 423,084,729 and 422,229,173, respectively. The Company reported net income attributable to the Company’s shareholders of $6,863,678 and $118,046 for the three months ended March 31, 2026, and 2025, respectively, resulting in basic and diluted earnings per share of $0.016 and $0.000, respectively.

 

The Company had no options, warrants, restricted stock units, convertible debt, or other potentially dilutive common stock equivalents outstanding during the three months ended March 31, 2026, or 2025. Accordingly, basic and diluted earnings per share are the same for each period presented.

 

Reclassifications

 

We have reclassified certain amounts from the prior period to conform to the current year’s presentation. None of these classifications impacted reported operating or net loss for any presented period.

 

F-19

 

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Recent Accounting Pronouncements

 

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific requirements. ASU 2014-09 establishes a five-step revenue recognition process; an entity will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires enhanced disclosures regarding the nature, amount, timing, and uncertainty of revenues and cash flows from customers’ contracts. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which defers the effective date of ASU 2014-09 by one (1) year. The Company adopted ASC 606 using the modified retrospective method, applying it to all contracts not completed as of January 1, 2019. The Company presents results for reporting periods beginning after January 1, 2019, under ASC 606, while prior period amounts are reported in accordance with legacy GAAP. Refer to Note 2, Revenue from Major Contracts with Customers, for further discussion on the Company’s accounting policies for revenue sources within the scope of ASC 606.

 

NOTE 3. MANAGEMENT’S PLANS

 

The Company has prepared its consolidated financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. As of March 31, 2026, and December 31, 2025, the Company had an accumulated surplus of $9,984,473 and $3,120,795, respectively, and a working capital surplus of $30,169,554 and $14,883,171, respectively.

 

For the three months ended March 31, 2026, and 2025, the Company generated net income of $6,869,920 and $104,548, respectively, and total revenues of $15,214,492 and $5,976,948, respectively, representing an increase in revenues of approximately 154.6% over the prior period. The improvement in the Company’s results of operations reflects strong revenue growth across the Margin Brokerage and Technology and Software Development segments, contributions from the Company’s recently acquired subsidiaries, and continued operating leverage on a largely fixed cost base. The accumulated surplus increased from $3,120,795 as of December 31, 2025, to $9,984,473 as of March 31, 2026, and the working capital surplus increased from $14,883,171 as of December 31, 2025, to $30,169,554 as of March 31, 2026.

 

Management has evaluated the Company’s ability to continue as a going concern in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Subtopic 205-40, Presentation of Financial Statements—Going Concern. In performing this evaluation as of the date these consolidated financial statements are issued, management considered, among other factors, the Company’s significantly improved results of operations during the three months ended March 31, 2026, including the revenue growth, profitability, and strengthened liquidity position described above, together with management’s continued execution of its strategic plan to streamline and integrate the Company’s recently acquired subsidiaries into a unified operating platform. Based on this evaluation, management has concluded that no conditions or events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern for at least twelve (12) months from the date these consolidated financial statements are issued. Accordingly, these consolidated financial statements have been prepared on a going concern basis, and no adjustments have been made to the carrying values of assets or liabilities that might result if the Company were unable to continue as a going concern.

 

As of March 31, 2026, the Company had a cash and cash equivalents balance of $36,891,541, which management believes, together with cash expected to be generated from operations, is sufficient to support its ongoing operations and to meet its current obligations as they become due in the ordinary course of business for at least twelve (12) months from the date these consolidated financial statements are issued. While management believes the Company has adequate liquidity to sustain its existing business activities, the Company’s strategic growth initiatives, particularly the continued development of its financial technology platforms, may require additional capital investment. In order to accelerate expansion and enhance its technology offerings, the Company may seek external financing through private placements of equity, public offerings, or credit facilities. There can be no assurance, however, that such financing will be available on acceptable terms, if at all.

 

Management remains focused on strengthening the Company’s financial position by expanding its global customer base, increasing revenue from its diversified portfolio of technology solutions, realizing operating synergies from the continued integration of its acquired subsidiaries, and working toward sustainable positive cash flow from operations. To support long-term growth, the Company also intends to invest in long-lived assets that are expected to generate economic benefits beyond fiscal year 2026. In addition, the Company is pursuing a potential listing of its common stock on a national securities exchange in connection with a proposed public offering. If completed, the proceeds of such offering would meaningfully enhance the Company’s liquidity position and capital resources; however, the completion, timing, and terms of any such offering are subject to market conditions and other factors, and there can be no assurance that the offering will be consummated.

 

F-20

 

 

NOTE 4. CAPITALIZED SOFTWARE COSTS

 

The Company’s capitalized software consists of internally developed software and software development costs capitalized in accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, and ASC 350-40, Internal-Use Software. The estimated useful life of the Company’s capitalized software is three (3) years, and amortization is recognized on a straight-line basis over such estimated useful life commencing when the underlying software is placed in service.

 

As of March 31, 2026, and December 31, 2025, the unamortized balance of capitalized software, including capitalized software of the Company’s subsidiaries, was $1,578,353 and $1,480,246, respectively. During the three months ended March 31, 2026, the Company capitalized $98,107 of software development costs. No software amortization expense was recognized during the three months ended March 31, 2026, or 2025, as the underlying software assets had not yet been placed in service.

 

A substantial portion of the $1,578,353 capitalized software balance as of March 31, 2026 relates to (i) software assets added in connection with, or shortly after, the acquisition of Alchemy International Ltd. (the change of control of which was approved on October 29, 2025, and which closed on November 11, 2025), and (ii) the ongoing development of the Condor Investing and Trading App. As of March 31, 2026, the related software assets had not yet been placed in service, and accordingly, the Company has not commenced amortization. Amortization will be recognized on a straight-line basis over the estimated three (3) year useful life upon the date each underlying software asset is placed in service.

 

The Company has estimated aggregate amortization expense for each of the succeeding fiscal years based on the estimated three (3) year useful life of the underlying software assets, commencing in the fiscal period in which such assets are placed in service.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

The Company has, from time to time, entered into transactions with related parties, including its founders, directors, principal shareholders, and entities controlled by them. The following describes related party balances and transactions as of and for the periods presented.

 

Nature of Relationships

 

The Company’s principal related parties are:

 

(i) Mr. Gope S. Kundnani, a Director of the Company and the beneficial owner of 180,000,000 shares of common stock (42.54%), 4,000,000 shares of Series A Preferred Stock (88.89%), and, through APSI Holdings Limited (a United Kingdom entity), 1,800,000 shares of Series B Convertible Preferred Stock (75.90%);

 

(ii) Mitchell M. Eaglstein and Imran Firoz, Co-Founders, Executive Officers, and Directors of the Company; and

 

(iii) certain non-consolidated affiliated entities controlled directly or indirectly by Mr. Kundnani, including Alchemy DMCC (United Arab Emirates), Alchemy Capital Markets (“ACM”) (United Kingdom), FXIFY Markets Ltd. (Labuan, Malaysia), and other Kundnani-affiliated sister entities, all of which are sister entities to the Company and not part of the consolidated group.

 

Related Party Receivables

 

Related party receivables totaled $30,154,645 as of March 31, 2026, compared to $37,477,356 as of December 31, 2025, a net decrease of $7,322,711 during the three months ended March 31, 2026.

 

As of March 31, 2026, the principal components of the related party receivable balance were: (i) approximately $26.8 million representing a net receivable from Alchemy DMCC, primarily reflecting Alchemy International Ltd.’s (“AIL”) approximately $28.1 million receivable from Alchemy DMCC, partially offset by smaller balances at FDCTech, Inc. and Alchemy Prime Limited; (ii) approximately $3.2 million representing a loan receivable carried by FDCTech, Inc. from FXIFY Markets Ltd., a non-consolidated affiliated sister entity controlled by Mr. Kundnani; and (iii) approximately $0.2 million of other balances, comprising residual intercompany timing differences after consolidation and balances held at unaffiliated payment institutions.

 

As of December 31, 2025, the related party receivable balance was comprised primarily of approximately $35.8 million carried by AIL representing current account receivables from ACM and related affiliates, as further described in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, supplemented by the loan receivable from FXIFY Markets Ltd. described above at FDCTech, Inc.

 

Related Party Advances Payable

 

Related party advances payable totaled $3,296,890 as of March 31, 2026, compared to $29,197,470 as of December 31, 2025, a net decrease of $25,900,580 during the three months ended March 31, 2026. As of March 31, 2026, the $3,296,890 balance was comprised primarily of approximately $2.7 million owed by Alchemy Prime Limited and approximately $0.6 million owed at the FDCTech, Inc. parent level, in each case to Kundnani-affiliated sister entities, with the remainder representing smaller balances at the Company’s other subsidiaries. The December 31, 2025 balance was comprised primarily of approximately $25.5 million owed by AIL to Alchemy DMCC, approximately $3.7 million owed at the FDCTech, Inc. parent level and across other subsidiaries to Kundnani-affiliated sister entities, and other smaller balances.

 

During the three months ended March 31, 2026, the Company settled a net $25,900,580 of related party advances through a combination of (i) cash repayments to the related-party counterparties and (ii) non-cash netting arrangements with Alchemy DMCC, including the transfer back to AIL of certain trading positions previously held with Alchemy DMCC and other liquidity arrangements designed to manage AIL’s counterparty risk exposures. As a result of these arrangements, AIL’s net position with Alchemy DMCC moved from a net advance payable as of December 31, 2025, to a net receivable of approximately $26.8 million as of March 31, 2026. The aggregate settlement of the related party advances payable is reflected as a financing outflow in the condensed consolidated statement of cash flows for the three months ended March 31, 2026.

 

Accrued Expenses to Related Parties

 

Accrued expenses to related parties totaled $997,259 as of March 31, 2026, compared to $532,287 as of December 31, 2025. These amounts primarily represent accrued executive compensation owed to Mr. Eaglstein, the Company’s Chief Executive Officer, and Mr. Firoz, the Company’s Chief Financial Officer (through Thinkatalyst LLC, a Delaware limited liability company controlled by Mr. Firoz), each compensated at $15,000 per month under independent-contractor arrangements.

 

Other Q1 2026 Related Party Transactions

 

Other than the settlements and accruals described above, the principal related party transactions during the three months ended March 31, 2026 consisted of (i) the continued accrual of executive compensation to Messrs. Eaglstein and Firoz at $15,000 per month each on an independent-contractor basis; (ii) the continuing obligation in the amount of $2,000,000 under non-interest bearing seller financing provided by Sync Capital Limited (a Seychelles entity controlled and owned by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company), in connection with the Company’s acquisition of Alchemy International Ltd., which obligation is repayable from the proceeds of the Company’s contemplated listing of its common stock on a national securities exchange and is presented as a component of Business acquisition loan on the consolidated balance sheets (see Note 7); and (iii) net activity in intercompany trading and rebate balances among the Company’s regulated subsidiaries (AML, APL, and AIL), all of which were eliminated in consolidation in accordance with ASC 810-10-45-1. There were no material new equity issuances, loans, or guarantees to or from related parties during the three months ended March 31, 2026.

 

Cross-Reference to Form 10-K/A

 

For additional historical background on related party transactions, including transactions prior to fiscal year 2025, refer to Item 13 (Certain Relationships and Related Transactions) of the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025 (filed April 22, 2026).

 

F-21

 

 

NOTE 6. LINE OF CREDIT

 

In June 2016, the Company obtained an unsecured revolving line of credit of $40,000 from Bank of America to fund various business purchases and travel expenses. The interest rates applicable to cash advances and other drawn amounts under this line of credit are 12% and 25%, respectively. In October 2024, the Company obtained an additional unsecured revolving line of credit with a flexible spending limit, under which no preset borrowing limit applies. The additional line of credit bears interest on purchases at an average rate of approximately 28% per annum.

 

As of March 31, 2026, the Company was in compliance with the terms and conditions of each of its lines of credit. As of March 31, 2026, and December 31, 2025, the aggregate outstanding balances under the lines of credit were $266,926 and $111,352, respectively.

 

NOTE 7. NOTES PAYABLE

 

CARES Act – Paycheck Protection Program (PPP Note)

 

On May 1, 2020, the Company received proceeds of $50,632 from a promissory note (the “PPP Note”) issued under the Paycheck Protection Program of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Note bears interest at a rate of 1.00% per annum. The PPP Note was not forgiven, and the Company commenced repayment of the PPP Note in August 2022. The PPP Note was repaid in full during the fiscal year ended December 31, 2025. As of March 31, 2026, and December 31, 2025, the outstanding balance of the PPP Note was $0 and $0, respectively.

 

SBA Loan

 

On May 22, 2020, the Company received proceeds of $144,900 under the U.S. Small Business Administration’s Economic Injury Disaster Loan (“EIDL”) program. The loan bears interest at a rate of 3.75% per annum on funds advanced. Installment payments of $707 per month, consisting of both principal and interest, are required, with the remaining principal and interest balance payable thirty (30) years from the date of the promissory note. As of March 31, 2026, and December 31, 2025, the non-current balance outstanding under the SBA loan was $103,552 and $105,678, respectively.

 

Business Acquisition Loan

 

As of March 31, 2026, and December 31, 2025, the Company had outstanding seller financing obligations incurred in connection with prior business acquisitions in the aggregate amount of $2,350,000 and $2,350,000, respectively, presented as Business acquisition loan on the consolidated balance sheets.

 

The $2,350,000 aggregate balance is comprised of:

 

(i) $350,000 representing the unpaid portion of the purchase consideration owed to the former shareholders of Alchemy Markets Ltd. (“AML”) in connection with the Company’s June 2023 acquisition of AML, which amount is currently the subject of litigation as described below; and

 

(ii) $2,000,000 representing seller financing provided by Sync Capital Limited, a Seychelles entity controlled and owned by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, in connection with the Company’s acquisition of Alchemy International Ltd. (“AIL”).

 

The $2,000,000 obligation to Sync Capital Limited is non-interest-bearing. Pursuant to the terms of the seller financing arrangement, the obligation becomes due and payable from the proceeds of the Company’s contemplated listing of its common stock on a national securities exchange (the “Uplisting”), and no other fixed maturity date has been established. The Company has not imputed interest on this obligation, as the lender is a controlling shareholder of the Company, and any imputed interest, if material, would be recognized as a deemed capital contribution from the controlling shareholder with no net effect on stockholders’ equity. No payments were made under this obligation during the three months ended March 31, 2026, or 2025. The $2,000,000 obligation to Sync Capital Limited is also disclosed as a related party transaction in Note 5. There can be no assurance as to the timing or consummation of the Uplisting, and the Company’s obligation to repay the $2,000,000 to Sync Capital Limited will remain outstanding until such time as the Uplisting is completed or the parties otherwise agree to alternative repayment terms.

 

 

As of March 31, 2026, the Company has accrued the $350,000 withheld final payment within Business acquisition loan on the consolidated balance sheets. Management, after consultation with legal counsel, is unable to predict the ultimate outcome of the AML Litigation or to estimate the range of possible additional loss, if any, beyond the amount currently accrued. Accordingly, no additional accrual has been recorded as of March 31, 2026. An adverse outcome in the AML Litigation could result in the Company being required to pay additional amounts to the Claimants, which could have a material adverse effect on the Company’s results of operations and financial condition in the period of resolution.

 

The $2,000,000 obligation to Sync Capital Limited is also disclosed as a related party transaction in Note 5.

 

F-22

 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

The Company is subject to various commitments and contingencies arising in the ordinary course of business. The following discussion summarizes the Company’s significant commitments and contingencies as of March 31, 2026.

 

Office Facility and Other Operating Leases

 

Irvine, California, USA (Company’s Headquarters)

 

Effective October 29, 2019, to the present, the Company leased office space at 200 Spectrum Center Drive, Suite 300, Irvine, CA 92618. As per the Commitment Term of the lease (“Agreement”), this Agreement shall continue on a month-to-month basis (any term after the Commitment Term, also known as “Renewal Term”). The Commitment Term and all subsequent Renewal Terms shall constitute the “Term.” The Company may terminate this Agreement by delivering to the lessor Form (“Exit Form”) at least one (1) whole calendar month before the month in which the Company intends to terminate this Agreement (“Termination Effective Month”). The Company is entitled to use the office and conference space if needed. The new rent payment or membership fee for the Irvine Office is $95 per month, compared to the previous rent payment or membership fee for the New York Office of $890 per month, which covers general and administrative expenses. This agreement is classified as a service contract rather than a lease under ASC 842 - Leases, and payments are accounted for as operating expenses rather than recognizing a Right-of-Use (ROU) asset or lease liability.

 

Brisbane, Australia (ADS Office)

 

Effective January 1, 2024, to the present, the Company has leased office space at Level 38, 71 Eagle Street, Brisbane City, QLD 4000, Australia. This lease will continue on a month-to-month basis. ADS may terminate this Agreement by delivering to the lessor at least one (1) whole calendar month before the month in which ADS intends to terminate the lease. ADS is entitled to use the office and conference space if needed. The new rent payment or membership fee for the ADS Office is approximately $125 per month and is included as a general and administrative expense. This agreement is classified as a service contract rather than a lease under ASC 842 - Leases, and payments are accounted for as operating expenses rather than recognizing a Right-of-Use (ROU) asset or lease liability.

 

Limassol, Cyprus Lease (Company’s Executive Rental)

 

From February 2019 to July 2023, the Company leased office space in Limassol District, Cyprus, from an unrelated party for a year. The office’s monthly rent payment is $1,750, which is included in the general and administrative expenses. From July 2023 to the present, the Company has leased a larger office space in the Limassol District, Cyprus, from an unrelated party for a one-year term. The office’s monthly rent payment is approximately $3,500, which is included in the general and administrative expenses. From July 2023 to the present, the Company has leased office space for its Chief Executive Officer. The office’s monthly rent payment is $3,500, which is included in the general and administrative expenses. The down payment for the lease was approximately $6,300. The lease is for one year and is renewable two months prior to the term’s end in June 2026. This agreement is classified as a residential rental contract rather than a commercial lease and does not create a Right-of-Use (ROU) asset under ASC 842.

 

Limassol, Cyprus Lease, Europe (ATECH Office)

 

Effective August 26, 2024, ATECH has entered into a Sublease Agreement for office premises located on the ground floor at 10A-10C Eleftheriou Venizelou Street, Limassol, Cyprus. The sublease is between Aldeon Property Partners Ltd (the “Sublessor”) and AlchemyTech Ltd (the “Sublessee”), with FDCTech, Inc. acting as the Guarantor. The leased premises are designated strictly for office use, and any other usage is explicitly prohibited under the terms of the agreement. The lease term is for twenty-four (24) months, commencing on October 1, 2024, and expiring on September 30, 2026. The lease agreement includes an option to extend the tenancy for up to two additional two-year terms. The rent is subject to a 5% increase for each renewal period. Under the agreement, the Sublessee is obligated to pay a total rent of €192,000 over the lease term, payable in monthly installments of €8,000 (or approximately $8,600) plus VAT. Under ASC 842 - Leases, this agreement qualifies as a lease, and the Company will recognize a Right-of-Use (ROU) asset and corresponding lease liability on its financial statements.

 

F-23

 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES (continued)

 

St. Julian, Malta (AML Office)

 

Effective July 11, 2024, to the present, AML leased office space with Regus Malta at Portomaso Business Center, Portomaso, St. Julian, PTM01, Malta. As per the lease, this agreement shall continue on a month-to-month basis (any term after the term, also known as “Renewal Term”). The term and all subsequent renewal terms shall constitute the “Term.” AML may terminate this agreement by delivering to Regus Malta at least one (1) whole calendar month before the month in which AML intends to terminate this lease. AML is entitled to use the office and conference space if needed. The rent payment or membership fee for the AML Office is €1,659 per month. This agreement is classified as a service contract rather than a lease under ASC 842 - Leases, and payments are accounted for as operating expenses rather than recognizing a Right-of-Use (ROU) asset or lease liability.

 

Tel Aviv, Israel (AML Sales Office)

 

Effective July 1, 2023, AML has entered into a service agreement with Mindspace Ltd. for the use of office space and related services at Menachem Begin 11, Ramat Gan, Israel. The agreement provides access to designated office space, common areas, and various business services, including internet connectivity, printing, and access to conference rooms. The agreement operates on a monthly, automatically renewing basis with a total monthly fee of $4,500 (including VAT). Additionally, an advance deposit of $6,300 was paid as security for the Company’s obligations under the agreement. Under the terms of the agreement, Mindspace retains full discretion over space allocation and may relocate the Company to a different office within the premises, provided that it gives prior notice. AML does not have exclusive control over a specific office unit, and Mindspace provides shared services across its facilities. The agreement does not create a lease under ASC 842 – Leases and is accounted for as a service contract. As a result, payments under this agreement are classified as operating expenses rather than recognizing a Right-of-Use (ROU) asset or lease liability.

 

London, United Kingdom (APL Office)

 

Effective December 20, 2024, APL entered into a lease agreement for office space located on the fifth floor at 142 Central Street, Clerkenwell, London, EC1V BAR. Agop Tanielian and Hourig Mercedes Tanielian hold the lease as landlords, and the Company, through its subsidiary Alchemy Prime Limited, is the tenant. The lease has a fixed term of five years, commencing in 2024 and expiring in 2029, with an annual rent of £112,500 (or $12,000 monthly), payable in quarterly installments. APL is also liable for service charges, insurance, rent, and maintenance responsibilities as specified in the agreement. The lease includes an option to terminate (“Break Clause”) on or after 2026, provided that a four-month written notice is given prior. Additionally, the agreement requires APL to restore the premises upon termination, including the removal of any alterations or fixtures made during the lease term. Under ASC 842 - Leases, this agreement qualifies as a lease, and the Company will recognize a Right-of-Use (ROU) asset and corresponding lease liability on its financial statements.

 

The total rental payment for the period ending March 31, 2026, was $83,753.

 

Employment Agreement

 

The Company compensates its Chief Executive Officer and its Chief Financial Officer at $15,000 per month each on an independent-contractor basis (see Note 5, Related Party Transactions – Accrued Expenses to Related Parties). For additional information regarding executive compensation, refer to Item 11 (Executive Compensation) of the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, filed with the SEC on April 22, 2026.

 

Accrued Interest

 

At March 31, 2026, and December 31, 2025, the cumulative accrued interest for the SBA loan and other non-current loans was $43,650 and $42,396, respectively.

 

F-24

 

 

NOTE 8. COMMITMENTS AND CONTINGENCIES (continued)

 

Pending Litigation

 

The Company and its subsidiaries are involved in the following legal proceedings:

 

Asher Alkoby, et al. v. FDCTech

 

This action is pending in the London Circuit Commercial Court under Claim Number LM-2024-000330, filed December 9, 2024. The claimants are Asher Alkoby and other former shareholders of Alchemy Markets Ltd. (“AML”), a Malta-incorporated broker that the Company purchased in June 2023. Following completion of the acquisition, the Company discovered that in 2019, the target company had anti-money laundering deficiencies and was fined by the Financial Intelligence Analysis Unit. An external audit also revealed that the previous shareholders had taken loans from the company that were never repaid, resulting in net capital being lower than disclosed during negotiations. Based on these findings, FDCTech withheld the final payment to the sellers.

 

The claimants are seeking approximately $1.02 million in amounts they allege are owing under the Share Sale Agreement, which they are seeking to rectify to make legally enforceable. The Company has counterclaimed for a declaration that the Share Sale Agreement is ineffective and unenforceable and seeks repayment of $915,000 paid to the sellers. On October 17, 2025, the Court granted the claimants permission to amend their claim to include a third claimant. The Company has prepared an Amended Defense and Counterclaim through Counsel, which was served May 9, 2025. A Costs and Case Management Conference took place on November 17, 2025. The trial is currently scheduled to take place in November 2026.

 

FDCTech, Inc. v. Intelligenceline.com, Fintelegram.com, et al.

 

This action is pending in the Superior Court of California, County of Orange. FDCTech alleges that the defendants, through their websites Intelligenceline.com, Fintelegram.com, and Criticalintel.com, published false and defamatory statements accusing the Company of fraud, illegal conduct, and regulatory violations. The Company claims these statements have caused significant reputational and financial harm, including lost business opportunities, and further alleges that the defendants engaged in an extortion scheme by demanding payment for the removal of defamatory content. The complaint asserts claims for defamation per se, defamation per quod, trade libel, and false light, seeking damages and injunctive relief. The complaint was filed in 2025 but had not yet been served as of December 31, 2025. A hearing took place on December 15, 2025, on the Company’s motion. FDCTech conducted the investigation and presented its findings during the management conference held on April 20, 2026. FDCTech is currently awaiting the court’s final judgment based on the outcome of the investigation.

 

Alchemy Markets Ltd. v. Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 104/2023)

 

This appeal is pending before the Court of Appeal (Inferior Jurisdiction) in Malta. On September 23, 2023, the Financial Intelligence Analysis Unit (“FIAU”) imposed an administrative penalty of €419,997 and a follow-up directive on Alchemy Markets Ltd. (formerly NSFX Limited), a subsidiary of the Company, based on a compliance examination conducted between November 25, 2019, and December 5, 2019. The examination occurred approximately four years prior to the decision and under different ownership and control of the subsidiary. The Company filed this appeal on October 19, 2023, challenging the decision-making process and the law on which it was based, asserting that the penalty is arbitrary and excessive. The Company seeks to overturn the administrative penalty and the follow-up directive imposed by FIAU. On October 24, 2025, a hearing was held for the Company to continue presenting evidence. The Court scheduled an additional hearing for the FIAU to cross-examine the Company’s witnesses for February 2, 2026, and then for April 15 2026, heard before Madam Justice Rachel Montebello, following which the matter will be adjourned for final legal submissions.

 

Alchemy Markets Ltd. v. L-Avukat tal-Istat u Il-Korp għall-Analizi ta’ Informazzjoni Finanzjarja (Ref: 159/2024)

 

This constitutional challenge is pending before the First Hall Civil Court (Constitutional Jurisdiction) in Malta and relates to the same September 23, 2023, FIAU decision described above. The Company filed this application on April 2, 2024, challenging: (i) the composition of the FIAU and its enabling law; (ii) the decision-making processes which allegedly breach the Company’s fundamental human right to a fair hearing; and (iii) that, given the penal nature of the penalty and in alleged breach of the Constitution of Malta, the Company was not adjudged by an independent court. The Company requests the Constitutional Court to set aside the FIAU decision in its entirety. A first procedural hearing took place on May 7, 2024, and the Company has brought its evidence in support of the claim. The case remains pending; the next hearing in the matter is scheduled for January 28, 2026.

 

Management is unaware of any other actions, suits, investigations, or proceedings (public or private) pending or threatened against or affecting the Company, its subsidiaries, or any of their respective assets, other than those described above and other than ordinary routine litigation incidental to the business.

 

Tax Compliance Matters

 

From its inception to the present, the Company’s officers have been paid as independent contractors. As of March 31, 2026, the Company believes its payroll tax liabilities are not yet estimated. The Company’s federal taxes are acceptable to the Internal Revenue Service.

 

F-25

 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT)

 

Authorized Shares

 

On February 12, 2021, the Company filed a Certificate of Amendment with the Secretary of State of Delaware to change the authorized shares. As amended at that time, the Company had the authority to issue 260,000,000 shares, consisting of 250,000,000 shares of Common Stock having a par value of $0.0001 per share and 10,000,000 shares of Preferred Stock having a par value of $0.0001 per share.

 

On February 17, 2022, the Company filed an Information Statement pursuant to Section 14C of the Securities Exchange Act of 1934 to increase the authorized Common Stock from 250,000,000 to 500,000,000 shares and to approve the Company’s 2022 Equity Plan. The Approving Stockholders (common stock only) owned 96,778,105 shares, representing 64.62% of the total issued and outstanding voting power of the Company.

 

Recent Corporate Actions – September 2025

 

On September 4, 2025, the Board of Directors unanimously approved, and the Company obtained the written consent of holders of a majority of the Company’s voting power for, corporate actions to (i) amend the Certificate of Incorporation to increase the authorized shares of common stock from 500,000,000 to 750,000,000 and the authorized shares of preferred stock from 10,000,000 to 15,000,000 and (ii) authorize the Board of Directors, in its discretion, to amend the Certificate of Incorporation not later than June 30, 2026 to effect a reverse stock split of all outstanding shares of common stock in a ratio of not less than 1-for-10 and not more than 1-for-100, to be determined by the Board. The amendment to the Certificate of Incorporation affecting the increase in authorized shares of common stock and preferred stock has been filed with the Secretary of State of the State of Delaware and is in effect as of March 31, 2026.

 

Certificate of Designation of Series B Convertible Preferred Stock

 

On March 24, 2026, the Company filed a Certificate of Designation of Series B Convertible Preferred Stock (the “Series B Certificate of Designation”) with the Secretary of State of the State of Delaware. The Series B Certificate of Designation designates 3,000,000 shares of the Company’s authorized preferred stock (par value $0.0001 per share) as “Series B Convertible Preferred Stock” and establishes the rights, preferences, privileges, and restrictions of such shares.

 

Holders of Series B Convertible Preferred Stock have no dividend rights except as may be declared by the Board of Directors in its sole and absolute discretion, out of funds legally available for that purpose. Each share is entitled to one (1) vote per share on all matters presented to stockholders, and holders generally vote together with holders of Common Stock as a single class. The vote or consent of holders of a majority of the outstanding Series B Convertible Preferred Stock is required for: (i) matters that by law require the approval of the outstanding shares of the Series B Convertible Preferred Stock as a separate class; (ii) any amendment to the rights, preferences, privileges, or powers of the Series B Convertible Preferred Stock that would have a material adverse effect on the Series B Convertible Preferred Stock; (iii) any increase in the aggregate authorized number of shares of Series B Convertible Preferred Stock; (iv) any action that reclassifies any outstanding shares into shares having priority as to dividends or assets senior to the Series B Convertible Preferred Stock; or (v) any amendment to the Company’s Certificate of Incorporation that materially and adversely affects the rights of the Series B Convertible Preferred Stock.

 

Each share of Series B Convertible Preferred Stock is convertible at the option of the holder, without payment of additional consideration, into shares of Common Stock at any time, at an initial conversion rate of one hundred (100) shares of Common Stock for each one share of Series B Convertible Preferred Stock, subject to adjustment as provided in the Series B Certificate of Designation. If the Company completes a public offering of $10,000,000 or more that includes an uplisting of the Common Stock to The Nasdaq Stock Market or the New York Stock Exchange, the conversion rate for the Series B Convertible Preferred Stock in connection with such qualifying public offering will be determined by the Board of Directors within a range of between one hundred (100) and ten (10) shares of Common Stock for each one share of Series B Convertible Preferred Stock. The Series B Certificate of Designation also includes customary anti-dilution adjustments for stock dividends, stock splits, combinations, and reclassifications affecting the Common Stock, and provides that no fractional shares of Common Stock will be issued upon conversion (any fractional share entitlement will be rounded up to the nearest whole share).

 

Shares of Series B Convertible Preferred Stock that are converted into Common Stock or are otherwise acquired by the Company are restored to the status of authorized but unissued shares of preferred stock, without designation as to class, and may thereafter be issued, but not as shares of Series B Convertible Preferred Stock. As of March 31, 2026, 2,371,844 shares of Series B Convertible Preferred Stock were issued and outstanding.

 

F-26

 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

 

Outstanding Capital Stock

 

As of March 31, 2026, and December 31, 2025, the Company had 423,084,729 and 423,084,729 common shares issued and outstanding, respectively.

 

As of March 31, 2026, and December 31, 2025, the Company had 4,500,000 and 4,500,000 Series A Preferred Stock issued and outstanding, respectively.

 

As of March 31, 2026, and December 31, 2025, the Company had 2,371,844 and 2,371,844 Series B Preferred Stock issued and outstanding, respectively. There were no issuances or repurchases of common or preferred stock during the three months ended March 31, 2026.

 

Series A Preferred Stock – Beneficial Ownership

 

The percentages below are calculated based on 4,500,000 shares of our Series A Preferred Stock issued and outstanding for the period ended March 31, 2026.

 

Name and Address(1) 

Title of 

Class (4)

 

Number of Shares

Beneficially

Owned

  

Percent of Class

 
Mitch Eaglstein  Series A Preferred   500,000    11.11%
Gope S. Kundnani (5)  Series A Preferred   4,000,000    88.89%
Officers and Directors as a group (2 persons)  Series A Preferred   4,500,000    100.00%

 

(4) Series A Preferred stock is entitled to fifty (50) non-cumulative votes per share on all matters presented to stockholders for action. On December 12, 2016, the Board agreed to issue 2,600,000, 400,000, and 1,000,000 shares of Preferred Stock to Mitchell Eaglstein, Imran Firoz, and Felix R. Hong, respectively, as the founders, in consideration of services rendered to the Company. As of December 31, 2022, the Company had 4,000,000 preferred shares issued and outstanding.
   
(5) In January 2023, Eaglstein and Firoz transferred 1,100,000 and 400,000 shares to Gope S. Kundnani, the Director of the Company. As of September 30, 2023, the Company had 4,000,000 preferred shares issued and outstanding, with Eaglstein, Kundnani, and Hong holding 1,500,000, 1,500,000, and 1,000,000 shares, respectively.

 

On November 30, 2023, the Company issued 2,500,000 Series A Preferred Stock to Kundnani, valued at $2,500,000. The Company will receive $2,500,000 in direct investment from Alchemy Prime Holdings Shareholder for Series A Preferred, valued at $1.00 per share.

 

On January 30, 2024, the Company’s board of directors adopted and approved the rescission and cancellation of (i) 1,000,000 shares of Series A Preferred Stock of the Company issued to Mitchell M. Eaglstein and (ii) 1,000,000 shares of Series A Preferred Stock of the Company issued to Felix R Hong.

 

F-27

 

 

NOTE 9. STOCKHOLDERS’ EQUITY (DEFICIT) (continued)

 

Series B Preferred Stock – Beneficial Ownership

 

The percentages below are calculated based on 2,371,844 shares of our Series B Preferred Stock issued and outstanding for the period ended March 31, 2026.

 

Name and Address(1) 

Title of

Class (6)

 

Number of

Shares

Beneficially

Owned

  

Percent of

Class

 
Alchemy Prime Holdings Ltd.  Series B Preferred   1,800,000    75.90%
Gope S. Kundnani  Series B Preferred   191,844    6.32%
Mitchell M. Eaglstein  Series B Preferred   150,000    6.32%
Imran Firoz  Series B Preferred   150,000    6.32%
FRH Group  Series B Preferred   50,000    2.11%
William B. Barnett  Series B Preferred   10,000    0.42%
Susan E. Eaglstein  Series B Preferred   10,000    0.42%
Nicky G. Kundnani  Series B Preferred   10,000    0.42%
Officers and Directors as a group (3 persons)  Series B Preferred   2,291,844    96.63%

 

(6) The Series B Preferred Stock is non-dilutive and is not subject to stock splits or any other adjustments to the Company’s common stock. Each share of Series B Preferred Stock can be converted into 100 shares of the Company’s common stock at any time by the holder of such shares. Series B Preferred Stock is entitled to one (1) vote per share on all matters presented to stockholders for action. As a result, 2,371,844 Series B Preferred Stock represents a 0.38% voting percentage on a fully diluted vote per share basis.

 

On November 30, 2023, the Company issued 1,800,000 Series B Preferred Stock to Kundnani, valued at $2,538,000, for the purchase of 49.90% of AML and 100% of APL.

 

On January 4, 2024, the Company issued 150,000 Series B preferred stock to Mitchell M. Eaglstein, CEO and Director, for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 150,000 Series B preferred stock to Imran Firoz, CFO and Director, for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 50,000 Series B preferred stock to FRH Group for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 10,000 Series B preferred stock to William B. Barnett, Esq., for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 10,000 Series B preferred stock to Susan E. Eaglstein for services valued at $1.41 per share.

 

On January 4, 2024, the Company issued 50,000 Series B preferred stock to Gope S. Kundnani for services valued at $1.41 per share.

 

On January 30, 2024, the Company issued 141,844 Series B preferred stock to Gope S. Kundnani for cash valued at $1.41 per share.

 

On February 07, 2025, the Company issued 10,000 Series B preferred stock to Nicky G. Kundnani for services valued at $1.41 per share.

 

Cross-Reference to Form 10-K/A

 

For a complete history of the Company’s authorized share capital, common stock issuances, and preferred stock issuances, refer to Note 9 (Stockholders’ Equity (Deficit)) in the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, filed with the SEC on April 22, 2026.

 

F-28

 

 

NOTE 10. WARRANTS

 

As of March 31, 2026, and December 31, 2025, the Company had no outstanding warrants. There were no warrant issuances, exercises, or expirations during the three months ended March 31, 2026.

 

NOTE 11. COMPREHENSIVE INCOME

 

The Company’s other comprehensive income (“OCI”) comprises foreign currency translation adjustments from subsidiaries that do not use the U.S. dollar as their functional currency.

 

The following table shows the changes in accumulated other comprehensive income (loss) (“AOCI”) by component for the three months ended March 31, 2026, and 2025:

 

Accumulated Comprehensive Income: 

Cumulative Foreign

Currency

Translation

 
Balance as of December 31, 2024  $278,498 
Other comprehensive income (loss), attributed to ADS   (71,036)
Other comprehensive income (loss), attributed to AML   (95,752)
Other comprehensive income (loss), attributed to APL   35,782 
Other comprehensive income (loss), attributed to ATECH   (9,131)
Total other comprehensive income (loss), as restated, December 31, 2024   (140,137)
Balance as of March 31, 2025  $138,361 

 

Accumulated Comprehensive Income: 

Cumulative Foreign

Currency

Translation

 
Balance as of December 31, 2025  $313,484 
Other comprehensive income (loss), attributed to ADS   (7)
Other comprehensive income (loss), attributed to AML   2,930 
Other comprehensive income (loss), attributed to APL   (5,940)
Other comprehensive income (loss), attributed to ATECH   5,445
Total other comprehensive income (loss), as restated, December 31, 2024   2,427 
Balance as of March 31, 2026  $315,911 

 

NOTE 12. OFF-BALANCE SHEET ARRANGEMENTS

 

We have no off-balance sheet arrangements affecting our liquidity, capital resources, market risk support, credit risk support, or other benefits.

 

NOTE 13. SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events occurring after March 31, 2026, through May 15, 2026, the date these unaudited consolidated financial statements were available to be issued, in accordance with ASC 855. On April 22, 2026, the Company filed its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission. Other than as disclosed elsewhere in these unaudited consolidated financial statements, the Company has identified no subsequent events that would require recognition or disclosure in these unaudited consolidated financial statements.

 

F-29

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This Quarterly Report Form 10-Q contains forward-looking statements. Our actual results could differ materially from those set forth as a result of general economic conditions and changes in the assumptions used in making such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “predict,” “potential,” “continue,” “expect,” “anticipate,” “future,” “intend,” “plan,” “believe,” “estimate,” “forecast” and similar expressions (or the negative of such expressions). Forward-looking statements include, but are not limited to, financial and operational information, the volatility of our stock price, current competitive conditions, and the impact of U.S. tariffs, trade barriers, and restrictions. The following discussion and analysis of our financial condition and results of operations should be read together with the unaudited condensed financial statements and accompanying notes and the other financial information appearing elsewhere in this report. The analysis set forth below is provided pursuant to applicable Securities and Exchange Commission regulations and is not intended to serve as a basis for projections of future events.

 

FDCTech, Inc. (“FDCTech,” “Company,” “we,” “us,” or “our”) is a financial technology company specializing in developing and delivering innovative software solutions and business services to the over-the-counter (OTC) brokerage and financial services industries. The Company provides a range of proprietary and third-party technology solutions, including its flagship Condor Trading Technology, which supports multi-asset trading, risk management, and pricing for forex, equities, commodities, and digital assets. FDCTech is a U.S.-based, fully reporting public company and currently trades under the symbol OTC: FDCT.

 

Founded in January 2016 as a back-office technology solution provider, FDCTech has transformed into a diversified global fintech platform through strategic acquisitions. Our growth trajectory includes the acquisitions of AD Advisory Services Pty Ltd. (2021), Alchemy Markets Ltd. (2022-2023), Alchemy Prime Limited (2023), and, most recently, Alchemy International Ltd. (2025), expanding our global footprint across Australia, Malta, the United Kingdom, Cyprus, Seychelles, and Mauritius.

 

 

FDCTech, Inc. is the parent holding company with the following wholly-owned and majority-owned subsidiaries:

 

Subsidiary   Ownership   Jurisdiction  

Primary

Business

  Markets   Technology
AD Advisory Services Ltd. (ADS)   51.00%   Australia   Wealth Management   Australia   Third-party software
Alchemy Markets Ltd. (AML)   100.00%   Malta   FX, CFDs, Stocks, Bonds   Europe (excl the United Kingdom)  

Condor Trading &

Third-party

Alchemy Prime Ltd. (APL)   100.00%   United Kingdom   FX, CFDs   United Kingdom   Condor Trading & Third-party
Alchemytech Ltd. (ATECH)   100.00%   Cyprus   Technology Services   Europe   Condor Trading
Alchemy International Ltd. (AIL)   100.00%   Seychelles   FX, CFDs   Asia   Condor Trading & Third-party
Xoala Asia (XOA)   100.00%   Mauritius   Payment Intermediary Services   Asia   Third-party
Prime Intermarket Group Eurasia (PIG)   100.00%   Mauritius   FX, CFDs   Asia   Condor Trading & Third-party

 

4

 

 

Our Business Segments

 

We operate through four complementary business segments:

 

Margin Brokerage: Through Alchemy Markets Ltd. (Malta, MFSA-regulated), Alchemy Prime Limited (UK, FCA-regulated), and Alchemy International Ltd. (Seychelles, FSA-regulated), we provide multi-asset trading services in forex, CFDs, equities, commodities, and digital assets to retail and institutional clients globally.

 

Wealth Management: Through AD Advisory Services Pty Ltd. (Australia, ASIC-regulated), we operate a wealth management business with 28 financial advisors managing and advising over $530 million in funds under advice under the aegis of our license, where we provide licensing solutions and financial planning services to these financial advisors.

 

Technology and Software Development: Through FDCTech and Alchemytech Ltd. (Cyprus), we develop and license our proprietary Condor Trading Technology suite, including the Condor Pro Multi-Asset Trading Platform and Condor Risk Management back-office system.

 

Payment Intermediary Services: Through Xoala Asia (Mauritius, FSC-licensed), we are developing a payment gateway, merchant acquiring, and cross-border payment capabilities to complement our brokerage and wealth management operations. This segment is in the early stages of development.

 

During the three months ended March 31, 2026, the Company generated total revenue of $15,214,492, an increase of $8,252,944 (140.9%) over total revenue of $5,976,948 for the three months ended March 31, 2025.

 

The substantial growth in revenue was driven primarily by the full-quarter contribution of Alchemy International Ltd. (“AIL”) following the change of control approved by the Seychelles Financial Services Authority on October 29, 2025, and the closing of the acquisition on November 11, 2025.

 

AIL, a Seychelles-licensed securities dealer (license SD136) regulated by the Financial Services Authority, broadened the Company’s regulated multi-asset brokerage footprint to include Seychelles in addition to Malta (AML, MFSA-regulated) and the United Kingdom (APL, FCA-regulated), and added a base of offshore brokerages, high-frequency traders, and institutional clients seeking regulated access to foreign exchange and multi-asset markets.

 

The full-quarter contribution from AIL during the three months ended March 31, 2026 (compared with no contribution during the three months ended March 31, 2025) accounted for the substantial majority of the year-over-year increase in the Margin Brokerage segment. The Technology and Software Development segment also contributed to the increase, while the Wealth Management segment was substantially flat compared with the prior-year period. The Company also benefited from continued operating leverage on a substantially fixed cost base.

 

The Company is also pursuing a potential listing of its common stock on a national securities exchange (the New York Stock Exchange or the Nasdaq Stock Market) in connection with a proposed public offering of equity securities. In connection with these initiatives, the Company has engaged Lucosky Brookman LLP as legal counsel and is in discussions with E.F. Hutton and ThinkEquity LLC as financial advisors. The completion of any such offering or listing is subject to market conditions and customary regulatory and exchange approvals, and no assurance can be given that any such transaction will be completed.

 

5

 

 

Financial Condition as of March 31, 2026

 

As of March 31, 2026, the Company had total assets of $72,195,266, compared to $63,771,196 as of December 31, 2025, representing an increase of $8,424,070, or approximately 13.2%. Total assets at March 31, 2026, were comprised primarily of cash and cash equivalents of $36,891,541, related party receivables of $30,154,645, accounts receivable (net of allowance for doubtful accounts) of $358,932, prepaid expenses (current and non-current) of $535,408, capitalized software (net) of $1,578,353, acquired intangible assets (net) of $1,250,397, right-of-use lease assets of $668,214, property and equipment (net) of $187,657, and other current and non-current assets aggregating $570,019.

 

The $8,424,070 increase in total assets during the three months ended March 31, 2026 was primarily attributable to: (i) an increase in cash and cash equivalents of $19,221,792, reflecting cash generated from operations and the receipt by Alchemy International Ltd. (“AIL”) of customer funds in connection with the expansion of its brokerage operations; partially offset by (ii) a decrease in related party receivables of $7,322,711, as further described in Note 5, principally reflecting the net effect of cash collections and non-cash netting arrangements with Alchemy DMCC during the period; (iii) a decrease in the fair value of trading positions for the firm of $1,111,487, reflecting the closing-out and transfer of certain trading positions in the ordinary course; and (iv) a decrease in other trade and tax receivables of $2,615,533, principally reflecting collections of receivables outstanding at year-end.

 

Total Liabilities

 

As of March 31, 2026, the Company had total liabilities of $38,582,773, compared to $41,360,599 as of December 31, 2025, representing a decrease of $2,777,826, or approximately 6.7%. Total liabilities at March 31, 2026 were comprised primarily of customer funds payable of $28,339,255, related party advances payable of $3,296,890, accrued expenses to related parties of $997,259, business acquisition loan of $2,350,000, accounts payable of $502,087, operating lease liabilities (current and non-current) of $668,214, the SBA loan and accrued non-current interest aggregating $147,202, deferred tax liabilities of $372,339, and other current liabilities of $1,909,527.

 

The $2,777,826 net decrease in total liabilities during the three months ended March 31, 2026 was primarily attributable to: (i) a decrease in related party advances payable of $25,900,580, principally reflecting the settlement of AIL’s net advances payable to Alchemy DMCC through a combination of cash repayments and non-cash netting arrangements as further described in Note 5; partially offset by (ii) an increase in customer funds payable of $22,525,367, reflecting growth in customer trading activity and customer deposits held by AIL in connection with the expansion of its brokerage operations; (iii) an increase in accrued expenses to related parties of $464,972, primarily representing accrued executive compensation; and (iv) an increase in accounts payable and line of credit of $491,449 in the aggregate, reflecting normal operating activity.

 

Stockholders’ Equity and Working Capital

 

As of March 31, 2026, total stockholders’ equity attributable to FDCTech, Inc. stockholders was $33,568,694, compared to $22,377,274 as of December 31, 2025, representing an increase of $11,191,420, or approximately 50.0%. Total stockholders’ equity, including noncontrolling interests, was $33,612,493 as of March 31, 2026, compared to $22,410,597 as of December 31, 2025. The components of stockholders’ equity as of March 31, 2026 consisted of preferred stock and common stock at par value, additional paid-in capital of $28,199,590, additional paid-in capital relating to Series B Preferred Stock of $3,344,063, subscription receivable of $(8,000,000), accumulated other comprehensive loss of $(2,427), and accumulated surplus of $9,984,473.

 

6

 

 

The $11,191,420 increase in stockholders’ equity attributable to FDCTech, Inc. stockholders during the three months ended March 31, 2026 was primarily attributable to: (i) net income attributable to FDCTech, Inc. shareholders of $6,863,678 for the period; and (ii) an increase in additional paid-in capital of $4,643,653 arising from a transaction between entities under common control accounted for in accordance with ASC 805-50, Transactions Between Entities Under Common Control, with the residual change reflecting movement in accumulated other comprehensive loss during the period. No new shares of the Company’s common stock or preferred stock were issued during the three months ended March 31, 2026.

 

Working capital, defined as total current assets less total current liabilities, was $30,169,554 as of March 31, 2026, compared to $14,883,171 as of December 31, 2025, representing an increase of $15,286,383, or approximately 102.7%. The increase in working capital reflects the combined effect of the increase in cash and cash equivalents and the settlement of the December 31, 2025, related party advances payable balance described above, partially offset by the increase in customer funds payable during the period. The Company’s improved working capital position, together with cash generated from operations, is expected to support the Company’s ongoing operations and growth initiatives for at least the next twelve months.

 

Note on Common Control Transactions Affecting Additional Paid-in Capital

 

The Company’s acquisitions of Alchemy Markets Ltd. (“AML”), Alchemy Prime Ltd. (“APL”), and Alchemy International Ltd. (“AIL”) were transactions between entities under common control, as each of AML, APL, and AIL was, at the date of the respective acquisition, controlled by Mr. Gope S. Kundnani, who is also a Director and the principal beneficial owner of the voting securities of the Company. Accordingly, the Company has accounted for these acquisitions in accordance with ASC 805-50, Transactions Between Entities Under Common Control. Under this guidance, the assets and liabilities of AML, APL, and AIL were recognized in the Company’s consolidated financial statements at the historical carrying values of the transferor on the respective dates of transfer, and no goodwill or intangible assets were recognized in connection with these common-control combinations. The difference between the consideration transferred by the Company and the historical carrying value of the net assets received was recorded as an adjustment to additional paid-in capital.

 

During the three months ended March 31, 2026, the Company recorded a net increase to additional paid-in capital of $4,643,653 in connection with the finalization of the consolidation entries relating to the acquisition of AIL, which was completed on November 11, 2025. The adjustment reflects the difference between the consideration transferred by the Company in connection with the AIL acquisition and AIL’s historical carrying value of net assets as of the acquisition date, the determination of which was finalized during the three months ended March 31, 2026. No new shares of the Company’s common stock or preferred stock were issued in connection with this adjustment, and the adjustment had no effect on the Company’s results of operations, cash flows, or total stockholders’ equity in the aggregate during the three months ended March 31, 2026, other than as reflected within the components of stockholders’ equity.

 

The Company’s acquisition of AD Advisory Services Pty Ltd. (“ADS”), an Australia-incorporated subsidiary, in which the Company acquired a 51% controlling interest, was not a transaction between entities under common control. The ADS acquisition was effected at arm’s length with an unrelated counterparty and was accounted for as a business combination under ASC 805-10, Business Combinations, using the acquisition method. Accordingly, the assets and liabilities of ADS were recognized at their estimated fair values as of the acquisition date, and goodwill of $1,250,397 was recognized in connection with the ADS acquisition, representing the excess of the consideration transferred over the fair value of the identifiable net assets acquired. The noncontrolling interest in ADS was measured at the proportionate share of the fair value of the identifiable net assets at the acquisition date. No adjustment to additional paid-in capital was recognized in connection with the ADS acquisition.

  

Financial Condition at December 31, 2025

 

As of December 31, 2025, the Company had total assets of $63,771,196, comprised primarily of cash and cash equivalents of $17,669,749, related party receivables of $37,477,356, accounts receivable, net of $3,902,316, capitalized software (net) of $1,480,246, and other balance-sheet items as further described in the Company’s Annual.

 

Report on Form 10-K/A for the fiscal year ended December 31, 2025.

 

Total liabilities at December 31, 2025, were $41,360,599, comprised primarily of related party advances payable of $25,900,580 (which were settled during the three months ended March 31, 2026 — see Note 5 to the unaudited condensed consolidated financial statements); accounts payable, accrued expenses, and other current liabilities; the SBA loan; the business acquisition loan; and lease and other obligations.

 

Total stockholders’ equity at December 31, 2025, was $22,377,274, including an accumulated surplus of $3,120,795. Working capital at December 31, 2025, was $14,883,171.

 

7

 

 

RESULTS OF OPERATIONS

 

Three Months Ended March 31, 2026, compared with Three Months Ended March 31, 2025

 

The following table sets forth, for the periods indicated, the principal components of the Company’s consolidated results of operations and the change between the comparative periods (dollar amounts in U.S. dollars):

 

   Three Months Ended March 31,   Change 
   2026   2025   $   % 
Revenues:                
Technology & software  $1,639,222    813,747    825,475    101.4%
Wealth management   1,565,852    1,534,852    31,000    2.0%
Brokerage   12,009,418    3,628,349    8,381,069    231.0%
Total revenue  $15,214,492    5,976,948    9,237,544    154.6%
Cost of sales:                    
Technology & software   -    184,284    (184,284)   (100.0)%
Wealth management   1,435,250    1,349,827    85,423    6.3%
Brokerage   2,148,088    1,583,278    564,810    35.7%
Total cost of sales  $3,583,338    3,117,389    465,949    14.9%
Gross profit  $11,631,154    2,859,559    8,771,595    306.7%
Operating expenses:                    
General and administrative   4,324,900    2,140,270    2,184,630    102.1%
Sales and marketing   404,302    276,204    128,098    46.4%
Depreciation   46,643    38,832    7,811    20.1%
Total operating expenses  $4,775,845    2,455,306    2,320,539    94.5%
Operating income  $6,855,309    404,253    6,451,056    1595.8%
Total other income (expense), net   14,611    (299,705)   314,316    (104.9)%
Income before provision for income taxes   6,869,920    104,548    6,765,372    6471.1%
Provision for income taxes   -    -    -    - 
Net income  $6,869,920    104,548    6,765,372    6471.1%

 

Revenue

 

Total revenue increased to $15,214,492 for the three months ended March 31, 2026, compared to $5,976,948 for the three months ended March 31, 2025, an increase of $9,237,544, or approximately 154.6%. The growth was driven primarily by the Margin Brokerage segment, which contributed $12,009,418 total revenue for the three months ended March 31, 2026, compared to $3,628,349 for the comparable prior-year period, representing an increase of $8,381,069, or approximately 231.0%. The increase in Margin Brokerage revenue reflects the full-quarter contribution of Alchemy International Ltd. (“AIL”) following the closing of the AIL acquisition on November 11, 2025 (with the change of control approved by the Seychelles Financial Services Authority on October 29, 2025), together with the continuing operations of the Company’s other regulated brokerage subsidiaries, Alchemy Markets Ltd. (“AML”) in Malta and Alchemy Prime Ltd. (“APL”) in the United Kingdom.

 

Technology and software revenue was $1,639,222 for the three months ended March 31, 2026, compared to $813,747 for the comparable prior-year period, representing an increase of $825,475, or approximately 101.4%, reflecting the expansion of the Company’s technology and platform services to its expanded broker-dealer client base. Wealth Management revenue was $1,565,852 for the three months ended March 31, 2026, compared to $1,534,852 for the comparable prior-year period, representing an increase of $31,000, or approximately 2.0%, and was substantially consistent with the prior-year period.

 

Cost of Sales and Gross Profit

 

Cost of sales was $3,583,338 for the three months ended March 31, 2026, compared to $3,117,389 for the three months ended March 31, 2025, an increase of $465,949, or approximately 14.9%. The increase in cost of sales principally reflects higher liquidity-provider, payment-processing, and clearing costs incurred in support of the Margin Brokerage and Wealth Management segments. The rate of increase in cost of sales was substantially lower than the rate of increase in revenue, principally as a result of (i) operating leverage on the Margin Brokerage segment’s fixed-cost base relative to substantially higher transaction volumes, and (ii) the run-off during the period of certain technology cost of sales recognized in the comparable prior-year period.

 

8

 

 

Gross profit was $11,631,154 for the three months ended March 31, 2026, compared to $2,859,559 for the three months ended March 31, 2025, an increase of $8,771,595, or approximately 306.7%. Consolidated gross margin was approximately 76.4% for the three months ended March 31, 2026, compared to approximately 47.8% for the three months ended March 31, 2025, principally reflecting the change in revenue mix toward the higher-margin Margin Brokerage segment.

 

Operating Expenses

 

Total operating expenses were $4,775,845 for the three months ended March 31, 2026, compared to $2,455,306 for the three months ended March 31, 2025, an increase of $2,320,539, or approximately 94.5%. The increase in total operating expenses reflects higher general and administrative expense of $4,324,900 (compared to $2,140,270 for the comparable prior-year period, representing an increase of $2,184,630, or approximately 102.1%), higher sales and marketing expense of $404,302 (compared to $276,204 for the comparable prior-year period, representing an increase of $128,098, or approximately 46.4%), and higher depreciation expense of $46,643 (compared to $38,832 for the comparable prior-year period, representing an increase of $7,811, or approximately 20.1%).

 

The increase in general and administrative expense principally reflects additional compliance, audit, legal, and personnel-related expenses to support the Company’s expanded operating footprint following the AIL acquisition, together with professional fees and other costs incurred in connection with the Company’s contemplated listing of its common stock on a national securities exchange and the related proposed public offering. The increase in sales and marketing expense reflects expanded promotional and marketing activities in support of the Company’s broader brokerage and technology client base, as further described in Note 2.

 

Operating Income

 

Operating income was $6,855,309 for the three months ended March 31, 2026, compared to operating income of $404,253 for the three months ended March 31, 2025, representing an increase of $6,451,056. The increase in operating income reflects the increase in gross profit described above, partially offset by the increase in total operating expenses described above.

 

Other Income (Expense), Net

 

Total other income (expense), net, was net other income of $14,611 for the three months ended March 31, 2026, compared to net other expense of $(299,705) for the three months ended March 31, 2025, an improvement of $314,316. Total other income (expense), net, for the three months ended March 31, 2026, consisted of other interest income (expense) of $132,492 (compared to $4,483 for the comparable prior-year period) and other income (expense) of $(117,881) (compared to $(304,188) for the comparable prior-year period). The change principally reflects foreign exchange gains and losses on transactions denominated in currencies other than the functional currency of the applicable subsidiary, interest income on operating cash balances, and other miscellaneous items.

 

Net Income and Earnings per Share

 

Net income was $6,869,920 for the three months ended March 31, 2026, compared to net income of $104,548 for the three months ended March 31, 2025, an increase of $6,765,372. No provision for income taxes was recorded for either period. Net income attributable to FDCTech, Inc. stockholders was $6,863,678 for the three months ended March 31, 2026 ($0.016 per share, basic and diluted), compared to net income attributable to FDCTech, Inc. stockholders of $118,046 for the three months ended March 31, 2025 ($0.000 per share, basic and diluted).

 

9

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

Cash, Working Capital and Overview

 

As of March 31, 2026, the Company had cash and cash equivalents of $36,891,541, compared to $17,669,749 as of December 31, 2025, representing an increase of $19,221,792, or approximately 108.8%. Working capital, defined as total current assets less total current liabilities, was $30,169,554 as of March 31, 2026, compared to $14,883,171 as of December 31, 2025, representing an increase of $15,286,383, or approximately 102.7%. The increase in working capital principally reflects the settlement of $25,900,580 of related party advances payable during the three months ended March 31, 2026, together with the continued generation of operating cash flow, partially offset by an increase in customer funds payable in connection with the expansion of the Company’s brokerage operations.

 

Cash Flows from Operating Activities

 

Net cash provided by operating activities was $40,727,261 for the three months ended March 31, 2026, compared to net cash provided by operating activities of $166,036 for the three months ended March 31, 2025. The increase in net cash provided by operating activities principally reflects (i) net income of $6,869,920 for the three months ended March 31, 2026 (compared to $104,548 for the comparable prior-year period); (ii) an increase in customer funds payable of $22,525,367, reflecting the expansion of the Company’s brokerage operations and customer trading activity at Alchemy International Ltd.; (iii) a decrease in related party receivables of $7,322,711, principally reflecting the net effect of cash collections and non-cash netting arrangements with related parties as further described in Note 5; (iv) a decrease in the fair value of trading positions for the firm of $1,111,487, reflecting the closing-out of certain trading positions in the ordinary course; (v) a decrease in tax receivables from subsidiaries of $2,615,533; and (vi) an increase in accrued expenses to related parties of $464,972 and an increase in accounts payable of $335,875; partially offset by (vii) a decrease in other current liabilities of $490,392 and an increase in gross accounts receivable of $170,517.

 

Cash Flows from Investing Activities

 

Net cash provided by investing activities was $4,547,098 for the three months ended March 31, 2026, compared to net cash provided by investing activities of $828,537 for the three months ended March 31, 2025. Net cash provided by investing activities for the three months ended March 31, 2026 principally consisted of (i) $4,643,653 representing changes in paid-in capital arising from a transaction between entities under common control accounted for in accordance with ASC 805-50, Transactions Between Entities Under Common Control, in connection with the Company’s prior acquisitions of subsidiaries under common control, as further described elsewhere in this Report; and (ii) $1,552 of net investment activity through a subsidiary, partially offset by (iii) capitalized software development costs of $98,107.

 

Cash Flows from Financing Activities

 

Net cash used in financing activities was $25,736,656 for the three months ended March 31, 2026, compared to net cash provided by financing activities of $1,027,563 for the three months ended March 31, 2025. Net cash used in financing activities for the three months ended March 31, 2026 principally consisted of (i) the $25,900,580 settlement of related party advances payable as further described in Note 5, and (ii) net repayments of $2,126 on the Company’s SBA loan, partially offset by (iii) net draws of $155,574 on the Company’s lines of credit and (iv) $10,476 of net activity attributable to noncontrolling interest.

 

Net Change in Cash

 

The Company’s cash and cash equivalents increased by $19,221,792 during the three months ended March 31, 2026, comprising net cash provided by operating activities of $40,727,261, net cash provided by investing activities of $4,547,098, net cash used in financing activities of $(25,736,656), and the effect of exchange rate changes on cash of $(315,911). Cash and cash equivalents were $36,891,541 as of March 31, 2026, compared to $17,669,749 as of December 31, 2025.

 

Long-Term Obligations and Capital Adequacy

 

As of March 31, 2026, the Company’s principal long-term contractual obligations consisted of (i) the SBA loan in the non-current principal amount of $103,552, which bears interest at a rate of 3.75% per annum and is scheduled to mature thirty (30) years from the date of the underlying promissory note; (ii) the Business acquisition loan of $2,350,000, comprising the $350,000 withheld portion of the purchase consideration owed to the former shareholders of Alchemy Markets Ltd. (which is currently the subject of litigation as further described in Note 7) and the $2,000,000 non-interest bearing seller financing obligation owed to Sync Capital Limited, an entity controlled and owned by Mr. Gope S. Kundnani, a Director and majority shareholder of the Company, which obligation is repayable from the proceeds of the Company’s contemplated listing of its common stock on a national securities exchange; (iii) operating lease liabilities (current and non-current) of $668,214 in the aggregate, principally relating to the Company’s office facilities (see Note 8); and (iv) deferred tax liabilities of $372,339 and accrued non-current interest of $43,650.

 

Management believes that the Company’s existing cash and cash equivalents, anticipated cash flows generated from operations, and available borrowings under its existing credit lines will be sufficient to fund the Company’s operations and meet its known contractual obligations and capital commitments for at least the twelve (12) months following the date of this Report. The Company may from time to time raise additional capital through private or public offerings of equity or debt securities, or through additional credit facilities, to support its strategic growth initiatives, including in connection with the Company’s contemplated listing of its common stock on a national securities exchange and any related underwritten public offering. There can be no assurance that additional capital, if needed, will be available on terms acceptable to the Company or at all.

 

10

 

 

GOING CONCERN CONSIDERATION

 

The Company has prepared its accompanying consolidated financial statements on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and other commitments in the ordinary course of business. In accordance with Accounting Standards Codification (“ASC”) 205-40, Presentation of Financial Statements — Going Concern, management has evaluated whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

 

As of March 31, 2026, the Company had cash and cash equivalents of $36,891,541, working capital of $30,169,554, total stockholders’ equity of $33,612,493, and an accumulated surplus of $9,984,473, compared to cash and cash equivalents of $17,669,749, working capital of $14,883,171, total stockholders’ equity of $22,410,597, and an accumulated surplus of $3,120,795 as of December 31, 2025. During the three months ended March 31, 2026, the Company generated revenues of $15,214,492 (compared to $5,976,948 for the three months ended March 31, 2025), net income of $6,869,920 (of which $6,863,678 was attributable to the stockholders of FDCTech, Inc. and $6,242 was attributable to noncontrolling interests, compared to consolidated net income of $104,548 for the three months ended March 31, 2025), and net cash provided by operating activities of $40,727,261 (compared to $166,036 for the three months ended March 31, 2025).

 

Based on management’s evaluation of the Company’s historical and projected operating cash flows, existing cash and cash equivalents, working capital position, accumulated surplus, available borrowing capacity under existing credit facilities, and known contractual obligations and capital commitments, management has concluded that the Company’s existing cash and cash equivalents and anticipated cash flows from operations are sufficient to fund the Company’s operations and meet its known obligations as they become due for at least the twelve months following the date of issuance of these consolidated financial statements. Accordingly, management has concluded that there is no substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

 

Critical Accounting Policies and Significant Judgments and Estimates

 

We have based our management’s discussion and analysis of our financial condition and results of operations on our financial statements, which we have prepared in accordance with U.S. generally accepted accounting principles. In preparing our financial statements, we must make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses for the reporting periods.

 

In more detail, we have described significant accounting policies in Note 2 of our annual financial statements included in our 10-K/A for the fiscal year ended December 31, 2025, filed with the SEC on April 22, 2026. We continually evaluate our critical accounting estimates and judgments, as required by our policies, and update them as necessary based on changing conditions.

 

11

 

 

JOBS Act Accounting Election

 

We are an “emerging growth company,” as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued after the enactment of the JOBS Act until those standards apply to private companies. As an emerging growth company, we have applied for an exemption; as a result, the Company may delay the adoption of certain accounting standards until the standards apply to private companies.

 

Off-Balance Sheet Arrangements and Contractual Obligations

 

We have not engaged in any off-balance sheet arrangements as defined in Item 303(c) of the SEC’s Regulation S-B. We had no relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes.

 

Recent Accounting Pronouncements

 

The Company evaluates all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”) for applicability and impact on its consolidated financial statements.

 

In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which requires public entities to disclose significant segment expenses regularly provided to the chief operating decision maker, an amount and description of other segment items, and additional segment information. The Company adopted ASU 2023-07 effective January 1, 2024, on a retrospective basis. The adoption did not have a material impact on the Company’s consolidated financial statements but expanded segment disclosures.

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public business entities to disclose, on an annual basis, specific categories in the rate reconciliation and information about income taxes paid by jurisdiction. ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024, with early adoption permitted. The Company will adopt ASU 2023-09 in its Annual Report on Form 10-K for the fiscal year ending December 31, 2026, and is currently evaluating the impact on its consolidated financial statement disclosures.

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40),” which requires public business entities to disclose disaggregated information about specific income statement expense categories. ASU 2024-03 is effective for public business entities for annual periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement disclosures.

 

Other recently issued ASUs not yet adopted by the Company are not expected to have a material impact on the Company’s consolidated financial statements when adopted.

 

For a more detailed description of our significant and critical accounting policies, please refer to Note 2 in the consolidated financial statements included in our Annual Report on Form 10-K/A for the year ended December 31, 2025, filed with the SEC on April 22, 2026.

 

12

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS.

 

Not Applicable.

 

ITEM 4. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer (together, the “Certifying Officers”), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Report.

 

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Certifying Officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

 

Management’s Report on Internal Controls over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule 13a-15(f) under the Securities Exchange Act, as amended. Management, with the participation of the Chief Executive Officer, evaluated the effectiveness of the Company’s internal control over financial reporting as of March 31, 2026. In making this assessment, management utilized the criteria established by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in its 2013 Framework for Internal Control. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of our consolidated financial statements for external reporting purposes in accordance with Generally Accepted Accounting Principles (GAAP). Our internal control over financial reporting includes those policies and procedures that:

 

(1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,

 

(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

 

(3) provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the consolidated financial statements.

 

Due to its inherent limitations, internal control over financial reporting may not be effective in preventing or detecting errors or misstatements in our consolidated financial statements. Additionally, projections of any evaluation of effectiveness in future periods are subject to the risk that controls may become inadequate due to changes in conditions or that the degree of compliance with policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting as of March 31, 2026. Based on our assessments, management determined that we did not maintain effective internal control over financial reporting as of March 31, 2026, due to the material weakness in our internal controls, including inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.

 

Management intends to implement remediation steps to enhance our internal controls, addressing inadequate segregation of duties within account processes, limited personnel resources, and insufficient written policies and procedures for accounting, IT, financial reporting, and record-keeping. We plan to further improve this process by enhancing the size and composition of our board upon the closing of the business, identifying third-party professionals with whom to consult regarding complex accounting applications, and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals and implemented additional layers of reviews in the internal controls and financial reporting process.

 

This Report does not include an attestation report from our independent registered public accounting firm, as we are an emerging growth company under the JOBS Act.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 under the Exchange Act that occurred during the three months ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

13

 

 

PART II.

 

ITEM 1. LEGAL PROCEEDINGS.

 

The Company and its subsidiaries are, from time to time, involved in legal proceedings arising in the ordinary course of business. The Company is currently a party to (or defending) the legal proceedings described in Note 8 (Commitments and Contingencies — Pending Litigation) to the unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report, which discussion is incorporated herein by reference.

 

Pursuant to Item 103 of Regulation S-K, the Company is required to disclose in this Item only those material pending legal proceedings, other than ordinary routine litigation incidental to the business, to which the Company or any of its subsidiaries is a party or of which any of their property is the subject, and any such proceeding involving a governmental authority where the monetary sanctions, exclusive of interest and costs, are reasonably expected to exceed $1,000,000. Based on the Company’s assessment, the amounts at issue in the proceedings described in Note 8 do not exceed 10% of the Company’s consolidated current assets, and the Company has determined that the proceedings described therein, individually or in the aggregate, do not currently rise to the level of “material” for purposes of Item 103. Notwithstanding this determination, the Company has elected to provide the more comprehensive descriptions in Note 8 to assist readers in understanding the Company’s litigation posture.

 

As of March 31, 2026, the Company has not recorded a loss accrual with respect to any of the matters described in Note 8, as Management has determined that any loss is not both probable and reasonably estimable as of that date. Management is unaware of any other material actions, suits, investigations, or proceedings (public or private) pending or threatened against or affecting the Company, its subsidiaries, or any of their respective assets, other than the matters described in Note 8 and other than ordinary routine litigation incidental to the business.

 

Item 1A. Risk Factors. 

 

In accordance with the requirements of Form 10-Q, the Company, as a smaller reporting company, is not required to disclose this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

There were no unregistered sales of the Company’s equity securities during the three months ended March 31, 2026, that were not previously reported in a Current Report on Form 8-K. For information regarding the Company’s prior unregistered issuances, refer to Item 5 (Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities) and Item 13 (Certain Relationships and Related Transactions) of the Company’s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2025, filed with the SEC on April 22, 2026.

 

Item 3. Defaults Upon Senior Securities.

 

None

 

Item 4. Mine Safety Disclosures.

 

None

 

Item 5. Other Information.

 

None

 

Item 6. Exhibits.

 

(a) Exhibits.

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

14

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  FDCTECH, INC.
   
Date: March 15, 2026 /s/ Mitchell Eaglstein
 

Mitchell Eaglstein, President and CEO

(Principal Executive Officer)

 

Date: March 15, 2026 /s/ Imran Firoz
 

Imran Firoz, CFO

(Principal Accounting Officer)

 

15

 

 

EXHIBIT INDEX

 

Exhibit   Item
     
31.1   Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

16

 

FAQ

How did FDCTech (FDCT) perform financially in Q1 2026?

FDCTech generated strong Q1 2026 results, with revenue of $15,214,492 and net income of $6,869,920. This compares to revenue of $5,976,948 and net income of $104,548 a year earlier, reflecting a significant improvement in profitability.

What drove FDCTech (FDCT) revenue growth in the quarter ended March 31, 2026?

Revenue growth was mainly driven by Brokerage (Trading), which produced $12,009,418 in Q1 2026. Technology and software contributed $1,639,222, and wealth management generated $1,565,852. Overall revenue increased about 154.6% versus the prior-year quarter.

What is FDCTech (FDCT) earnings per share for Q1 2026?

For Q1 2026, FDCTech reported basic and diluted earnings per share of $0.016. This is based on a weighted average of 423,084,729 common shares outstanding and compares with essentially breakeven EPS of $0.000 in the prior-year period.

What does FDCTech (FDCT) say about its going concern status?

Management concluded no conditions or events raise substantial doubt about FDCTech’s ability to continue as a going concern for at least twelve months. This view reflects higher revenues, net income of $6.9M, working capital surplus of $30.2M, and cash of $36.9M.

How strong is FDCTech (FDCT) liquidity as of March 31, 2026?

FDCTech reported cash and cash equivalents of $36,891,541 at March 31, 2026, up from $17,669,749 at year-end 2025. Total current assets were $67,750,730 against current liabilities of $37,581,176, resulting in a working capital surplus of $30,169,554.

How many FDCTech (FDCT) shares are outstanding and what preferred stock exists?

As of March 31, 2026, FDCTech had 423,084,729 common shares, 4,500,000 Series A Preferred shares, and 2,371,844 Series B Preferred shares outstanding. Each Series B share is currently convertible into 100 common shares, subject to possible adjustment upon a qualifying public offering and uplisting.